合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of 2,4-dichloro-5-fluorobenzoyl chloride (I) with diethyl malonate (II) by means of magnesium ethoxide in ether gives diethyl 2,4-dichloro-5-fluorobenzoylmalonate (III), which is partially hydrolyzed and decarboxylated with p-toluenesulfonic acid water yielding ethyl 2,4-dichloro-5-fluorobenzoylacetate (IV). The condensation of (IV) with triethyl orthoformate (V) in refluxing acetic anhydride affords ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxyacrylate (VI), which is treated with cyclopropylamine (VII) in ethanol to give ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-cyclopropylaminoacrylate (VIII). The cyclization of (VIII) with NaH in refluxing dioxane yields 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (IX), which is finally condensed with piperazine (X) in hot DMSO.
【1】
Reddy, P.G.; Baskaran, S.; Microwave assisted amination of quinolone carboxylic acids: An expeditious synthesis of fluoroquinolone antibacterials. Tetrahedron Lett 2001, 42, 38, 6775.
|
【2】
Grohe, K.; Zeiler, H. J.; Metzger, K.G. (Bayer AG); 1-Cyclopropyl-6-fluoro-1,4-dihidro-4-oxo-7-piperazino-quinoline-3-carboxilic acids, process for their preparation and antibacterial agents containing them. EP 0078362; JP 4253963; JP 58074667 .
|
【3】
Serradell, M.N.; Castaner, J.; Ciprofloxacin. Drugs Fut 1984, 9, 3, 179.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22093 |
2,4-dichloro-5-fluorobenzoyl chloride
|
86393-34-2 |
C7H2Cl3FO |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
22095 |
diethyl 2-(2,4-dichloro-5-fluorobenzoyl)malonate
|
|
C14H13Cl2FO5 |
详情 |
详情
|
(IV) |
22096 |
ethyl 3-(2,4-dichloro-5-fluorophenyl)-3-oxopropanoate
|
|
C11H9Cl2FO3 |
详情 |
详情
|
(V) |
21304 |
Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether
|
122-51-0 |
C7H16O3 |
详情 | 详情
|
(VI) |
22098 |
ethyl (Z)-2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxy-2-propenoate
|
|
C14H13Cl2FO4 |
详情 |
详情
|
(VII) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(VIII) |
22100 |
ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl)-2-propenoate
|
|
C15H14Cl2FNO3 |
详情 |
详情
|
(IX) |
30340 |
ethyl 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
86483-54-7 |
C15H13ClFNO3 |
详情 | 详情
|
(X) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) This compound can be prepared in two different ways:
1) The reaction of 1,4-dichloro-2-butene (I) with diethyl malonate (II) by means of sodium ethoxide in refluxing ethanol gives 1,1-bis(ethoxycarbonyl)-2-vinylcyclopropane (III), which by reaction with ammonia gas in DMF at 120 C is converted into 3-carboxamido-5-vinyl-2-pyrrolidone (IV). Finally, this compound is treated with concentrated HCl in refluxing acetic acid.
2) The treatment of (IV) with sodium ethoxide in refluxing ethanol gives 3-carboxy-5-vinyl-2-pyrrolidone (V), which is decarboxylated by treatment with refluxing acetic acid to afford 5-vinyl-2-pyrrolidone (VI). The bromination of (VI) with Br2 in CCl4 yields 5-(1,2-dibromoethyl)-2-pyrrolidone (VII), which by treatment with Na in liquid NH3 in a pressure vessel at 25 C is converted into 4-aminohex-5-inoic acid (VIII). Finally, this compound is partially reduced with H2 over a suitable catalyst.
【1】
Gittos, M.W.; Leterre, G.J.; Process for making 4-aminohex-5-enoic acid. FR 2415630; GB 2013205; JP 54112860; US 4178463 .
|
【2】
Metcalf, B.W.; Jung, M.; Olefinic derivatives of amino acids. US 4039549 .
|
【3】
Metcalf, B.W.; Jung, M.; Olefinic derivatives of amino acids. CA 1077487; FR 2304329; GB 1472525; JP 76125320; US 3960927 .
|
【4】
Blancafort, P.; Paton, D.M.; Serradell, M.N.; Castaner, J.; RMI-71,754. Drugs Fut 1981, 6, 6, 363.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32186 |
(E)-1,4-dichloro-2-butene
|
110-57-6 |
C4H6Cl2 |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
32187 |
Diethyl 2-vinyl-1,1-cyclopropanedicarboxylate
|
|
C11H16O4 |
详情 |
详情
|
(IV) |
32188 |
2-Oxo-5-vinyl-3-pyrrolidinecarboxamide; 3-Carboxamido-5-vinyl-2-pyrrolidone
|
71107-19-2 |
C7H10N2O2 |
详情 | 详情
|
(V) |
32189 |
2-oxo-5-vinyl-3-pyrrolidinecarboxylic acid
|
|
C7H9NO3 |
详情 |
详情
|
(VI) |
32190 |
5-Vinyl-2-pyrrolidinone
|
|
C6H9NO |
详情 |
详情
|
(VII) |
32191 |
5-(1,2-dibromoethyl)-2-pyrrolidinone
|
|
C6H9Br2NO |
详情 |
详情
|
(VIII) |
32192 |
4-amino-5-hexynoic acid
|
|
C6H9NO2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(A) Chlorination of 4-amino-3-trifluoromethylbenzoic acid (I) gives 4-amino-3-chloro-5-trifluoromethylbenzoic acid (II), which is transformed in two steps to 4'-amino-3'-chloro-5'-trifluoromethylacetophenone (IV) by means of its acid chloride (III) and diethyl malonate. UV-catalyzed bromination with bromine in glacial acetic acid at 60-65 C gives the corresponding alpha-bromoketone (V). Reaction of (V) with tert-butylamine in isopropanol at 20 C leads to 4'-amino-2-tert-butylamino-3'-chloro-5'-trifluoromethylacetophenone (VI), which, without isolation, is reduced with sodium borohydride to the base (VII) of the title compound. The latter is obtained by treatment of (VII) with hydrochloric acid in diethyl ether. The optical isomers of mabuterol have been separated via the diastereomeric esters obtained by treating the racemate with (-)-methoxvcarbonyl chloride.
【1】
Kruger, G.; Keck, J.; Noll, K.; Pieper, H.; Synthesis of futher amino-halogen substituted phenylaminoethanols. Arzneim-Forsch Drug Res 1984, 34, 11a, 1612.
|
【2】
Kruger, G.; Engelhardt, G.; Mabuterol Hydrochloride. Drugs Fut 1985, 10, 11, 913.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(I) |
29777 |
4-amino-3-(trifluoromethyl)benzoic acid
|
|
C8H6F3NO2 |
详情 |
详情
|
(II) |
29778 |
4-amino-3-chloro-5-(trifluoromethyl)benzoic acid
|
|
C8H5ClF3NO2 |
详情 |
详情
|
(III) |
29779 |
4-amino-3-chloro-5-(trifluoromethyl)benzoyl chloride
|
|
C8H4Cl2F3NO |
详情 |
详情
|
(IV) |
29780 |
1-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-ethanone
|
|
C9H7ClF3NO |
详情 |
详情
|
(V) |
29781 |
1-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-2-bromo-1-ethanone
|
|
C9H6BrClF3NO |
详情 |
详情
|
(VI) |
29782 |
1-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-2-(tert-butylamino)-1-ethanone
|
|
C13H16ClF3N2O |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) Alkylation of diethyl malonate (II) with 5-(4-chlorophenyl)pentyl bromide (I) gives diethyl 5-(4-chlorophenyl)pentyl malonate (III). Intermediate (III) is hydrolyzed to the monoester (IV), followed by condensation with paraformaldehyde in pyridine/piperidine to yield ethyl 7-(4-chlorophenyl)-2-methyleneheptanoate (V), which is oxidized with m-chloroperbenzoic acid.
Alternatively, intermediate (IV) can be prepared by condensation of 4-chlorocinnamaldehyde (VI) with diethyl ethylidenemalonate (VII) to yield intermediate (VIII) and subsequent hydrogenation.
【1】
Eistetter, K.; Wolf, H.P.O.; Synthesis and hypoglycaemic activity of phenylalkyloxirane carboxylic acid derivatives. J Med Chem 1982, 25, 22, 109-113.
|
【2】
Eistetter, K.; Rapp, E. (Byk Gulden Lomberg Chemische Fabrik GmbH); Substd. oxiranecarboxylic acids, their use and medicaments containing them. US 4324796 .
|
【3】
Kohl, B.; Eistetter, K.; Amschler, H.; Ludwig, G.; Wolf, H.P.O. (Byk Gulden Lomberg Chemische Fabrik GmbH); Phenylalkyloxirane carboxylic acids, preparation and therapeutical use. EP 0071175 .
|
【4】
Wolf, H.P.O.; Eistetter, K.; POCA. Drugs Fut 1983, 8, 5, 428.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36082 |
1-(5-bromopentyl)-4-chlorobenzene
|
|
C11H14BrCl |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
36083 |
diethyl 2-[5-(4-chlorophenyl)pentyl]malonate
|
|
C18H25ClO4 |
详情 |
详情
|
(IV) |
36085 |
7-(4-chlorophenyl)-2-(ethoxycarbonyl)heptanoic acid
|
|
C16H21ClO4 |
详情 |
详情
|
(V) |
35086 |
1-benzyl 4-(tert-butyl) (2R,3S)-2-isobutyl-3-(3-[[(4-nitrophenoxy)carbonyl]oxy]propyl)butanedioate
|
|
C29H37NO9 |
详情 |
详情
|
(VI) |
36087 |
(E)-3-(4-chlorophenyl)-2-propenal
|
|
C9H7ClO |
详情 |
详情
|
(VII) |
36088 |
(E)-2-(ethoxycarbonyl)-2-butenoic acid
|
|
C7H10O4 |
详情 |
详情
|
(VIII) |
36084 |
(2E,4E,6E)-7-(4-chlorophenyl)-2-(ethoxycarbonyl)-2,4,6-heptatrienoic acid
|
|
C16H15ClO4 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) 1) Alkylation of diethyl malonate (II) with 1 6-dibromohexane (I) results in diethyl 6-bromohexylmaionate (III). Compound (II) is hydrolyzed to the monoester (IV), followed by condensation with paraformaldehyde in ethanol/piperidine/2-methylquinoline to yield ethyl 8-bromo-2-methyleneoctanoate (V), which is oxidized with permaleic acid to (VI). Subsequent reaction with 4-chlorophenolate produces etomoxir.
【1】
Eistetter, K.; Ludwig, G.; Rapp, E.; Wolf, H. (Byk Gulden Lomberg Chemische Fabrik GmbH); Phenoxyalkoxyalkyl- and phenoxyalkyl-substd. oxiranecarboxylic acids, their use and medicaments containing them. EP 0046590; US 4337267 .
|
【2】
Eistetter, K.; Wolf, H.P.O.; ETOMOXIR. Drugs Fut 1986, 11, 12, 1034.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
62997 |
4-chlorobenzenolate
|
|
C6H4ClO |
详情 |
详情
|
(I) |
24786 |
1,6-dibromohexane
|
629-03-8 |
C6H12Br2 |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
24864 |
diethyl 2-(6-bromohexyl)malonate
|
|
C13H23BrO4 |
详情 |
详情
|
(IV) |
24865 |
8-bromo-2-(ethoxycarbonyl)octanoic acid
|
|
C11H19BrO4 |
详情 |
详情
|
(V) |
24866 |
ethyl 2-(6-bromohexyl)acrylate
|
|
C11H19BrO2 |
详情 |
详情
|
(VI) |
24867 |
ethyl 2-(6-bromohexyl)-2-oxiranecarboxylate
|
|
C11H19BrO3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) 2) Alternatively, etomoxir can be prepared as follows: Alkylation of 4-chlorophenol with 1,6-dibromohexane (I) yields 1 bromo-6-(4-chlorophenoxy)hexane (VII). Diethyl malonate (II) is alkylated by (VII), yielding (VIII), followed by hydrolysis to the monoester (IX), which is condensed with para formaldehyde/pyridine/piperidine to give ethyl 8-(4-chlorophenoxy)-2-methyleneoctanoate (IX). Oxidation with m-chloroperbenzoic acid produces etomoxir.
【1】
Eistetter, K.; Ludwig, G.; Rapp, E.; Wolf, H. (Byk Gulden Lomberg Chemische Fabrik GmbH); Phenoxyalkoxyalkyl- and phenoxyalkyl-substd. oxiranecarboxylic acids, their use and medicaments containing them. EP 0046590; US 4337267 .
|
【2】
Eistetter, K.; Wolf, H.P.O.; ETOMOXIR. Drugs Fut 1986, 11, 12, 1034.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
35543 |
4-chlorophenol
|
106-48-9 |
C6H5ClO |
详情 | 详情
|
(I) |
24786 |
1,6-dibromohexane
|
629-03-8 |
C6H12Br2 |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(VII) |
24870 |
6-bromohexyl 4-chlorophenyl ether
|
|
C12H16BrClO |
详情 |
详情
|
(VIII) |
24871 |
diethyl 2-[6-(4-chlorophenoxy)hexyl]malonate
|
|
C19H27ClO5 |
详情 |
详情
|
(IX) |
24872 |
8-(4-chlorophenoxy)-2-(ethoxycarbonyl)octanoic acid
|
|
C17H23ClO5 |
详情 |
详情
|
(X) |
24873 |
ethyl 2-[6-(4-chlorophenoxy)hexyl]acrylate
|
|
C17H23ClO3 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The condensation of 3-bromo-5-isoxazolylcarbonyl chloride (I) with diethyl malonate (II) gives the corresponding malonyl derivative (III), which is submitted to a decarboxylative hydrolysis yielding 5-acetyl-3-bromoisoxazole (IV). Bromination of (IV) affords 5-(bromoacetyl)-3-bromoisoxazole (V), which is reduced to 2-bromo-1-(3-bromo-5-isoxazolyl)ethanol (VI). Title compound is obtained by reaction of (VI) with tert-butylamine directly or via oxirane (VII), which is obtained by reaction of (VI) with sodium hydride, and finally by reaction of (VII) with tert-butylamine.
【1】
Fantucci, M.; Sala, R.; Chiarino, D.; Frigeni, V.; Della Bella, D.; Carenzi, A.; New isoxazole derivatives with a potent and select. Farm Sci Ed 1986, 41, 6, 440.
|
【2】
Chiarino, D.; Della Bella, D. (Zambon Group SpA); 1-(3-Bromo-isoxazol-5-yl)-2-tert-butylaminoethanol. JP 1980108862; US 4276299 .
|
【3】
Castaner, J.; Prous, J.; Broxaterol. Drugs Fut 1987, 12, 2, 107.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22864 |
3-bromo-5-isoxazolecarbonyl chloride
|
|
C4HBrClNO2 |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
22866 |
diethyl 2-[(3-bromo-5-isoxazolyl)carbonyl]malonate
|
|
C11H12BrNO6 |
详情 |
详情
|
(IV) |
22867 |
1-(3-bromo-5-isoxazolyl)-1-ethanone
|
|
C5H4BrNO2 |
详情 |
详情
|
(V) |
22868 |
2-bromo-1-(3-bromo-5-isoxazolyl)-1-ethanone
|
|
C5H3Br2NO2 |
详情 |
详情
|
(VI) |
22869 |
2-bromo-1-(3-bromo-5-isoxazolyl)-1-ethanol
|
|
C5H5Br2NO2 |
详情 |
详情
|
(VII) |
22870 |
3-bromo-5-(2-oxiranyl)isoxazole
|
|
C5H4BrNO2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) This compound can be obtained by three related ways:
1) The condensation of 3-cyclopentyloxy-4-methoxybenzaldehyde (I) with diethyl malonate (II) by means of piperidine in refluxing acetic acid gives diethyl 3-cyclopentyloxy-4-methoxybenzylidenemalonate (III), which is treated with nitromethane and tetramethylguanidine (TMG) yielding diethyl 2-[1-(3-cyclopentyloxy-4-methoxyphenyl)-2-nitroethyl]malonate (IV). The reductocyclization of (IV) with H2 over Raney Ni in hot methanol gives ethyl 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-oxopyrrolidine-3-carboxylat (V). Finally, this compound is hydrolyzed and decarboxylated.
2) The reaction of malonate (III) with KCN in ethanol at 60 C gives ethyl 3-cyano-3-(3-cyclopentyloxy-4-methoxyphenyl)propionate (VI), which is reduced with H2 over PtO2 in acetic acid yielding ethyl 4-amino-3-(3-cyclopentyloxy-4-methoxyphenyl)butanoate (VII). Finally, this compound is hydrolyzed and cyclized.
3) The reaction of malonate (III) with KNC in refluxing ethanol gives 3-cyano-3-(3-cyclopentyloxy-4-methoxy)propanoic acid (VIII), which is reduced with H2 over PtO2 as before yielding 4-amino-3-(3-cyclopentyloxy-4-methoxyphenyl)butanoic acid (IX). Finally, this compound is cyclized.
【1】
Huth, A.; Schmiechen, R.; Kehr, W.; Palenschat, D.; Paschelke, G.; Wachtel, H. (Schering AG); 4-(Polyalkoxyphenyl)-2-pyrrolidones (II).. BE 846335; ES 451518; FR 2324299; GB 1563398; US 4153713 .
|
【2】
Crossland, J.; Prous, J.; Castaner, J.; ROLIPRAM < Rec INN; USAN >. Drugs Fut 1988, 13, 1, 38.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16510 |
3-(cyclopentyloxy)-4-methoxybenzaldehyde
|
|
C13H16O3 |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
21586 |
diethyl 2-[3-(cyclopentyloxy)-4-methoxybenzylidene]malonate
|
|
C20H26O6 |
详情 |
详情
|
(IV) |
21587 |
diethyl 2-[1-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-nitroethyl]malonate
|
|
C21H29NO8 |
详情 |
详情
|
(V) |
21588 |
ethyl 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-oxo-3-pyrrolidinecarboxylate
|
|
C19H25NO5 |
详情 |
详情
|
(VI) |
21589 |
ethyl 3-cyano-3-[3-(cyclopentyloxy)-4-methoxyphenyl]propanoate
|
|
C18H23NO4 |
详情 |
详情
|
(VII) |
21590 |
ethyl 4-amino-3-[3-(cyclopentyloxy)-4-methoxyphenyl]butanoate
|
|
C18H27NO4 |
详情 |
详情
|
(VIII) |
21591 |
3-cyano-3-[3-(cyclopentyloxy)-4-methoxyphenyl]propionic acid
|
|
C16H19NO4 |
详情 |
详情
|
(IX) |
21592 |
4-amino-3-[3-(cyclopentyloxy)-4-methoxyphenyl]butyric acid
|
|
C16H23NO4 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) The condensation of cinnamic nitrile (I) with diethyl malonate (II) by means of K2CO3 and tetrabutylammonium bromide in refluxing acetone or NaOEt in refluxing ethyl acetate gives 2-[2-cyano-1-(4-fluorophenyl)ethyl]malonic acid diethyl ester (III), which is cyclized by reduction of its cyano group with H2 over PtO2 in ethanol/conc. HCl or over Ru/C in ethanol to yield (rac)-(trans)-4-(4-fluorophenyl)-2-oxopiperidine-3-carboxylic acid ethyl ester (IV). Finally, this compound is reduced with NaBH4 in THF to afford (rac)-(trans)-4-(4-fluorophenyl)-3-(hydroxymethyl)piperidine (V), the target intermediate.
【1】
Dalmases Barjoan, P.; Carulla Oliver, J.M.; Moreno Manas, M.; Perez, M. (Laboratorios Vita, SA); Piperidinone deriv., process for obtaining it and process for using it. ES 2137131 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56466 |
(E)-3-(4-fluorophenyl)-2-propenenitrile
|
|
C9H6FN |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
56467 |
1-ethyl 3-methyl 2-[2-cyano-1-(4-fluorophenyl)ethyl]malonate
|
|
C15H16FNO4 |
详情 |
详情
|
(IV) |
56468 |
ethyl (3S,4R)-4-(4-fluorophenyl)-2-oxo-3-piperidinecarboxylate
|
|
C14H16FNO3 |
详情 |
详情
|
(V) |
43487 |
[(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidinyl]methanol; trans-(3S)-4-(4-fluorophenyl)-1-methyl-3-piperidine methanol
|
105812-81-5 |
C13H18FNO |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) 1) The condensation of 2,4-dichloro-5-fluoro-benzoyl chloride (I) with diethyl malonate (II) by means of magnesium ethoxide gives diethyl 2,4-dichloro-5-fluorobenzoylmalonate (III), which is partially decarboxylated with p-toluenesulfonic acid yielding ethyl 2,4-dichloro-5-fluorobenzoylacetate (IV). The condensation of (IV) with triethyl orthoformate (V) by means of refluxing acetic anhydride affords ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxyacrylate (VI), which is treated with cyclopropylamine (VII) in ethanol giving ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-(cyclopropylamino)acrylate (VII). The cyclization of (VII) by means of NaH in refluxing dioxane yields 1-cyclopropyl-7-chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (IX), which is finally condensed with N-ethylpiperazine (X) by heating at 140 C in DMSO.
【1】
Grohe, K.; Klimetzek, V.; Metzger, K.G.; Stunkel, K.G.; Zeiler, H.-J. (Bayer AG); Immunostimulant agent. AU 8542762; DE 3420116; EP 0165474; ES 8607020; JP 1985258163; US 4659603 .
|
【2】
Grohe, K.; Petersen, U.; Kuck, K.-H. (Bayer AG); Antimicrobial agent of quinolone-carboxylic acid b. DE 3248507; US 4563459 .
|
【3】
Castaner, J.; Prous, J.; Enrofloxacin. Drugs Fut 1988, 13, 4, 305.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22093 |
2,4-dichloro-5-fluorobenzoyl chloride
|
86393-34-2 |
C7H2Cl3FO |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
22095 |
diethyl 2-(2,4-dichloro-5-fluorobenzoyl)malonate
|
|
C14H13Cl2FO5 |
详情 |
详情
|
(IV) |
22096 |
ethyl 3-(2,4-dichloro-5-fluorophenyl)-3-oxopropanoate
|
|
C11H9Cl2FO3 |
详情 |
详情
|
(V) |
21304 |
Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether
|
122-51-0 |
C7H16O3 |
详情 | 详情
|
(VI) |
22098 |
ethyl (Z)-2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxy-2-propenoate
|
|
C14H13Cl2FO4 |
详情 |
详情
|
(VII) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(VIII) |
22100 |
ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl)-2-propenoate
|
|
C15H14Cl2FNO3 |
详情 |
详情
|
(IX) |
22101 |
7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
86393-33-1 |
C13H9ClFNO3 |
详情 | 详情
|
(X) |
14213 |
N-Ethylpiperazine; 1-Ethylpiperazine
|
5308-25-8 |
C6H14N2 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(VIII) The reduction of 2,3,4-trichloro-5-fluoronitrobenzene (I) with Fe - HCl in hot water gives 2,3,4-trichloro-5-fluoroaniline (II), which by diazotation with NaNO2 - HCl and reaction with sodium tetrafluoroborate and cuprous cyanide is converted to 2,3,4-trichloro-5-fluorobenzonitrile (III). The reaction of (III) with KF in DMSO at 140 C affords 3-chloro-2,4,5-trifluorobenzonitrile (IV), which by hydrolysis with 30% HBr in refluxing acetic acid gives 3-chloro-2,4,5-trifluorobenzamide (V). The hydrolysis of (V) with 18N H2SO4 at 135 C yields the corresponding benzoic acid (VI), which is treated with refluxing SOCl2 to afford the acyl chloride (VII). The condensation of (VII) with diethyl malonate (VIII) by means of Mg - ethanol in hot toluene gives diethyl 3-chloro-2,4,5-trifluorobenzoylmalonate (IX), which is partially decarboxylated with p-toluenesulfonic acid in refluxing water to give ethyl 3-chloro-2,4,5-trifluorobenzoylacetate (X). The condensation of (X) with triethyl orthoformate (XI) in refluxing acetic anhydride yields ethyl 2-(3-chloro-2,4,5-trifluorobenzoyl)-3-ethoxyacrylate (XII), which is treated with cyclopropylamine (XIII) in ethanol to afford ethyl 2-(3-chloro-2,4,5-trifluorobenzoyl)-3-(cyclopropylamino)acrylate (XIV).
The cyclization of (XIV) by means of NaF in DMF at 150 C gives ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate (XV), which is hydrolyzed with H2SO4 in refluxing water - acetic acid to the corresponding carboxylic acid (XVI). The condensation of (XVI) with 3-(tert-butoxycarbonylamino)pyrrolidine (XVII) by means of 1,8-diazabicyclo [5.4.0]undecane (DBU) in refluxing acetonitrile yields 7-[3-(tert-butoxycarbonylamino)-1-pyrrolidinyl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (XVIII), which is finally deprotected by a treatment with concentrated HCl in methanol.
【1】
Irikura, T.; Suzue, S.; Murayama, S.; Hirai, K.; Ishizaki, T. (Kyorin Pharmaceutical Co., Ltd.); 7-(1-Pyrrolidinyl)-3-quinolinecarboxylic acid derivs.. AU 8542829; AU 8654272; EP 0195316; EP 0195841; ES 8606330; ES 8704932; JP 1986205235; JP 1986205237; JP 1986205238; JP 1986205239; JP 1986205258; JP 1986205259 . |
【2】
Serradell, M.N.; Castaner, J.; Castaner, R.M.; Saito, H.; Tomioka, H.; Sato, K.; Hirai, K.; Suzue, S.; AM-1091. Drugs Fut 1989, 14, 10, 931.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21294 |
2,3,4-trichloro-1-fluoro-5-nitrobenzene
|
|
C6HCl3FNO2 |
详情 |
详情
|
(II) |
21295 |
2,3,4-trichloro-5-fluorophenylamine; 2,3,4-trichloro-5-fluoroaniline
|
|
C6H3Cl3FN |
详情 |
详情
|
(III) |
21296 |
2,3,4-trichloro-5-fluorobenzonitrile
|
|
C7HCl3FN |
详情 |
详情
|
(IV) |
21297 |
3-chloro-2,4,5-trifluorobenzonitrile
|
|
C7HClF3N |
详情 |
详情
|
(V) |
21298 |
3-chloro-2,4,5-trifluorobenzamide
|
|
C7H3ClF3NO |
详情 |
详情
|
(VI) |
11678 |
3-Chloro-2,4,5-trifluorobenzoic acid
|
|
C7H2ClF3O2 |
详情 |
详情
|
(VII) |
11679 |
3-Chloro-2,4,5-trifluorobenzoyl chloride
|
|
C7HCl2F3O |
详情 |
详情
|
(VIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(IX) |
21302 |
diethyl 2-(3-chloro-2,4,5-trifluorobenzoyl)malonate
|
|
C14H12ClF3O5 |
详情 |
详情
|
(X) |
11681 |
ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate
|
101987-86-4 |
C11H8ClF3O3 |
详情 | 详情
|
(XI) |
21304 |
Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether
|
122-51-0 |
C7H16O3 |
详情 | 详情
|
(XII) |
11682 |
ethyl (Z)-2-(3-chloro-2,4,5-trifluorobenzoyl)-3-ethoxy-2-propenoate
|
|
C14H12ClF3O4 |
详情 |
详情
|
(XIII) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(XIV) |
11683 |
ethyl (E)-2-(3-chloro-2,4,5-trifluorobenzoyl)-3-(cyclopropylamino)-2-propenoate
|
|
C15H13ClF3NO3 |
详情 |
详情
|
(XV) |
21308 |
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C15H12ClF2NO3 |
详情 |
详情
|
(XVI) |
11684 |
8-Chloro-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
101987-89-7 |
C13H8ClF2NO3 |
详情 | 详情
|
(XVII) |
21310 |
tert-butyl 3-pyrrolidinylcarbamate
|
99724-19-3 |
C9H18N2O2 |
详情 | 详情
|
(XVIII) |
21311 |
7-[3-[(tert-butoxycarbonyl)amino]-1-pyrrolidinyl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C22H25ClFN3O5 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(VIII) A new synthesis for KB-5246 has been described:
The reaction of 2,3,4-trifluoroaniline (I) with carbon disulfide (II) and triethylamine gives the corresponding dithiocarbamate (III), which by cyclization with 1-acetoxy-3-chloro-2-propanone (IV) in ethyl acetate yields 4-(acetoxymethyl)-3-(2,3,4-trifluorophenyl)thiazole-2(3H)-thione (V). The cyclization of (V) with potassium hydroxide in refluxing ethanol-water affords 6,7-difluoro-1H,4H-thiazolo[4,3-c][1,4]benzoxazine-1-thione (VI), which is treated with trichloromethyl chloroformate in hot toluene to give the thiazolium chloride (VII), which is not isolated. The in situ reaction of (VII) with diethyl malonate by means of triethylamine in toluene gives (6,7-difluoro-1H,4H-thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonic acid diethyl ester (IX), which is cyclized again with polyphosphoric acid (PPA) at 115 C to afford 7,8-difluoro-5-oxo-9,1-(epoxymethano)-5H-thiazolo[3,2-a]quinoline-4-carboxylic acid ethyl ester (X). The hydrolysis of (X) with oleum gives the corresponding acid (XI), which is finally condensed with N-methylpiperazine (XII) in hot DMSO.
【1】
Kondo, H.; Tsukamoto, G.; Taguchi, M.; Jinbo, Y.; Kawahata, Y.; Sakamoto, F.; Inoue, Y.; Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials. J Med Chem 1992, 35, 1, 94.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13059 |
2,3,4-Trifluorophenylamine; 2,3,4-Trifluoroaniline
|
3862-73-5 |
C6H4F3N |
详情 | 详情
|
(III) |
13060 |
2,3,4-trifluorophenylcarbamodithioate
|
|
C7H3F3NS2 |
详情 |
详情
|
(IV) |
13061 |
2-(chlorooxy)-2-oxoethyl acetate
|
|
C4H5ClO4 |
详情 |
详情
|
(V) |
13062 |
[2-thioxo-3-(2,3,4-trifluorophenyl)-2,3-dihydro-1,3-thiazol-4-yl]methyl acetate
|
|
C12H8F3NO2S2 |
详情 |
详情
|
(VI) |
13063 |
6,7-Difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazine-1-thione
|
|
C10H5F2NOS2 |
详情 |
详情
|
(VII) |
13064 |
1-Chloro-6,7-difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazin-10-ium chloride
|
|
C10H5Cl2F2NOS |
详情 |
详情
|
(VIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(IX) |
13066 |
diethyl 2-(6,7-difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonate
|
|
C17H15F2NO5S |
详情 |
详情
|
(X) |
13067 |
ethyl 5,6-difluoro-8-oxo-3H,8H-4-oxa-1-thia-9b-azacyclopenta[cd]phenalene-9-carboxylate
|
|
C15H9F2NO4S |
详情 |
详情
|
(XI) |
13068 |
5,6-Difluoro-8-oxo-3H,8H-4-oxa-1-thia-9b-azacyclopenta[cd]phenalene-9-carboxylic acid
|
|
C13H5F2NO4S |
详情 |
详情
|
(XII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) The reaction of 2,3,4-trifluoroaniline (I) with carbon disulfide and triethylamine gives triethylammonium N-(2,3,4-trifluorophenyl)dithiocarbamate (II), which by reaction with ethyl chlorocarbonate in chloroform yields the corresponding isothiocyanate (III). The condensation of (III) with diethyl malonate (IV) by means of NaH in THF affords the sodium salt of diethyl [(2,3,4-trifluoroanilino)(mercapto)methylene]malonate (V), which is condensed with 1-acetoxy-3-chloroacetone in DMF to give the substituted thioester (VII). The cyclization of (VII) by means of sulfuric acid yields the thiazoline derivative (VIII), which is cyclized again by means of NaH in refluxing dioxane to afford diethyl (6,7-difluoro-1H,4H-thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonate (IX). A final, new cyclization of (IX) by means of ethyl polyphosphate (PPE) at 138 C, followed by hydrolysis of the intermediate ester with sulfuric acid gives 7,8-difluoro-9,1-epoxymethano-5-oxo-5H-thiazolo[3,2-a]quinoline-4-carboxylic acid (X). This compound is then condensed with 1-methylpiperazine (XI) in hot DMSO and treated with aqueous HCl.
【1】
Taguchi, M.; Kondo, H.; Inoue, Y.; Kawahata, Y.; Tsukamoto, G. (Kanebo Pharmaceuticals, Ltd.); Quinolinecarboxylic acid derivs., a compsns. comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments. EP 0286089; JP 1989199979; US 4808584 . |
【2】
Prous, J.; Castaner, J.; KB-5246. Drugs Fut 1989, 14, 6, 519.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13059 |
2,3,4-Trifluorophenylamine; 2,3,4-Trifluoroaniline
|
3862-73-5 |
C6H4F3N |
详情 | 详情
|
(II) |
20905 |
N,N-dipropyl-1-propanaminium 2,3,4-trifluorophenylcarbamodithioate
|
|
C16H25F3N2S2 |
详情 |
详情
|
(III) |
20906 |
1,2,3-trifluoro-4-isothiocyanatobenzene; 2,3,4-trifluorophenyl isothiocyanate
|
119474-40-7 |
C7H2F3NS |
详情 | 详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
20908 |
sodium 3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-(2,3,4-trifluoroanilino)-1-propene-1-thiolate
|
|
C14H13F3NNaO4S |
详情 |
详情
|
(VI) |
20909 |
4-chloro-3-oxobutyl acetate
|
|
C6H9ClO3 |
详情 |
详情
|
(VII) |
20910 |
diethyl 2-[[[2-(acetoxy)acetyl]sulfanyl](2,3,4-trifluoroanilino)methylene]malonate
|
|
C18H18F3NO7S |
详情 |
详情
|
(VIII) |
20911 |
diethyl 2-[4-(hydroxymethyl)-3-(2,3,4-trifluorophenyl)-1,3-thiazol-2(3H)-ylidene]malonate
|
|
C17H16F3NO5S |
详情 |
详情
|
(IX) |
13066 |
diethyl 2-(6,7-difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonate
|
|
C17H15F2NO5S |
详情 |
详情
|
(X) |
13068 |
5,6-Difluoro-8-oxo-3H,8H-4-oxa-1-thia-9b-azacyclopenta[cd]phenalene-9-carboxylic acid
|
|
C13H5F2NO4S |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(I) The cyclization of diethyl malonate (I) with cis-1,4-dichloro-2-butene (II) by means of LiH in DMF gives 3-cyclopentene-1,1-dicarboxylic acid diethyl ester (III), which is monodecarboxylated by hydrolysis with NaOH in ethanol, followed by heating at 170-180 C to yield 3-cyclopentene-1-carboxylic acid (IV). The reaction of (IV) with SOCl2 affords the acyl chloride (V), which by reaction with ethanol provides the ethyl ester (VI). The oxidation of (VI) with OsO4 and N-methylmorpholine N-oxide (NMMO) in acetone/water gives the dihydroxy compound (VII), which is further oxidized with NaIO4 in THF to yield the dialdehyde (VIII). The cyclization of (VIII) by means of glycine ethyl ester and acetonedicarboxylic acid affords the 9-azabicyclo[3,3,1]nonan-3-one derivative (IX), which is reduced with NaBH4 in ethanol to provide the corresponding alcohol (X). The protection of the OH group of (X) with dihydropyran and methanesulfonic acid gives the tetrahydropyranyl ether (XI), which is cyclized by means of tBuO-K in hot toluene, yielding the tricyclic ketone (XII). The deprotection of (XII) with 5N HCl affords the alcohol (XIII), which is finally esterified with 1H-indole-3-carbonyl chloride (XIV) by means of tetrafluoroboric acid and silver tetrafluoroborate in nitroethane.
Alternatively, 1H-indole (XV) is condensed with oxalyl chloride (XVI) to give 3-indolylglyoxylyl chloride (XVII), which is used to acylate the alcohol (XIII) by means of tetrafluoroboric acid and silver tetrafluoroborate as before. Simultaneous decarbonylation takes place in this acylation reaction.
【1】
Gittos, M.W. (Merrell Pharmaceuticals, Inc.); Esters of hexahydro-8-hydroxy-2, 6-methano-2H-quinolizin-3(4H)-one and related compds.. AU 8780596; EP 0266730; JP 1988258476 .
|
【2】
Gittos, M.W.; Fatmi, M.; Potent 5-HT3 antagonists incorporating a novel bridged pseudopelletierine ring system. Actual Chim Ther 1989, 16, 187.
|
【3】
Gittos, M.W.; Fatmi, M.; Galvan, M.; Dolasetron Mesylate. Drugs Fut 1993, 18, 6, 506.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
50004 |
cis-1,4-Dichloro-2-butene;(Z)-1,4-Dichlorobutene;(Z)-1,4-Dichloro-2-butene;(2Z)-1,4-Dichloro-2-butene;cis-1,2-Bis(chloromethyl)ethene |
1476-11-5 |
C4H6Cl2 |
详情 | 详情
|
(III) |
50000 |
diethyl 3-cyclopentene-1,1-dicarboxylate
|
|
C11H16O4 |
详情 |
详情
|
(IV) |
50001 |
3-cyclopentene-1-carboxylic acid
|
|
C6H8O2 |
详情 |
详情
|
(V) |
50002 |
3-Cyclopentenecarboxylic acid
|
7686-77-3 |
C6H7ClO |
详情 | 详情
|
(VI) |
13469 |
ethyl 3-cyclopentene-1-carboxylate
|
|
C8H12O2 |
详情 |
详情
|
(VII) |
13470 |
ethyl 3,4-dihydroxycyclopentanecarboxylate
|
|
C8H14O4 |
详情 |
详情
|
(VIII) |
13471 |
ethyl 4-oxo-2-(2-oxoethyl)butanoate
|
|
C8H12O4 |
详情 |
详情
|
(IX) |
13472 |
ethyl 9-(2-ethoxy-2-oxoethyl)-7-oxo-9-azabicyclo[3.3.1]nonane-3-carboxylate
|
|
C15H23NO5 |
详情 |
详情
|
(X) |
13473 |
ethyl 9-(2-ethoxy-2-oxoethyl)-7-hydroxy-9-azabicyclo[3.3.1]nonane-3-carboxylate
|
|
C15H25NO5 |
详情 |
详情
|
(XI) |
13474 |
ethyl 9-(2-ethoxy-2-oxoethyl)-7-(tetrahydro-2H-pyran-2-yloxy)-9-azabicyclo[3.3.1]nonane-3-carboxylate
|
|
C20H33NO6 |
详情 |
详情
|
(XII) |
50003 |
5-(tetrahydro-2H-pyran-2-yloxy)-8-azatricyclo[5.3.1.0(3,8)]undecan-10-one
|
|
C15H23NO3 |
详情 |
详情
|
(XIII) |
13475 |
5-Hydroxy-8-azatricyclo[5.3.1.0(3,8)]undecan-10-one
|
|
C10H15NO2 |
详情 |
详情
|
(XIV) |
17153 |
1H-indole-3-carbonyl chloride
|
|
C9H6ClNO |
详情 |
详情
|
(XV) |
15292 |
Indole; 1H-indole
|
120-72-9 |
C8H7N |
详情 | 详情
|
(XVI) |
29841 |
Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride
|
79-37-8 |
C2Cl2O2 |
详情 | 详情
|
(XVII) |
13476 |
Indole-3-glyoxylyl chloride; 2-(1H-Indol-3-yl)-2-oxoacetyl chloride
|
22980-09-2 |
C10H6ClNO2 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(XI) Alternatively, the condensation of dimethyl malonate (VI) with benzaldehyde (VII) by means of piperidine in refluxing toluene gives dimethyl benzylidenemalonate (VIII), which is reduced with H2 over Pd/C in toluene to yield the corresponding benzyl derivative (IX). The hydrolysis of (IX) with NaOH in water affords the benzylmalonic acid (X).
Alternatively, intermediate (X) can also be obtained starting from diethyl malonate (XI), which is condensed with with benzaldehyde (VII) by means of piperidine in refluxing toluene to give diethyl benzylidenemalonate (XII). Reduction of (XII) with H2 over Pd/C in toluene yields the corresponding benzyl derivative (XIII), which is then hydrolized with NaOH in water.
The monodecarboxylation of (X) and its condensation with paraformaldehyde and diethylamine in refluxing ethyl acetate provides 2-benzylacrylic acid (XIV), which is condensed with thioacetic acid (V) by heating at 70 C to afford 2-(acetylsulfanylmethyl)-3-phenylpropionic acid (XV). Finally, this compound is condensed with N-tosylglycine benzyl ester (XVI) by means of HOBt, DCC and TEA in THF.
【1】
Roques, B.; Schwartz, J.-C.; Lecomte, J.-M. (Societe Civile Bioprojet); Amino acid derivs. and their therapeutic application. EP 0038758 .
|
【2】
Lecomte, J.-M.; Duhamel, P.; Danvy, D.; Schwartz, J.-C.; Duhamel, L.; Monteil, T. (Societe Civile Bioprojet); Process for the synthesis of alpha-substd. acrylic acids and their application. EP 0729936 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
12893 |
Ethanethioic S-acid
|
|
C2H4OS |
详情 |
详情
|
(VI) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(VII) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(VIII) |
49460 |
Dimethyl benzylidenemalonate
|
|
C12H12O4 |
详情 |
详情
|
(IX) |
49461 |
dimethyl 2-benzylmalonate
|
|
C12H14O4 |
详情 |
详情
|
(X) |
37280 |
2-benzylmalonic acid
|
616-75-1 |
C10H10O4 |
详情 | 详情
|
(XI) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XII) |
37482 |
diethyl 2-benzylidenemalonate
|
5292-53-5 |
C14H16O4 |
详情 | 详情
|
(XIII) |
20208 |
diethyl 2-benzylmalonate
|
607-81-8 |
C14H18O4 |
详情 | 详情
|
(XIV) |
37279 |
2-benzylacrylic acid
|
|
C10H10O2 |
详情 |
详情
|
(XV) |
55230 |
3-(acetylsulfanyl)-2-benzylpropanoic acid
|
|
C12H14O3S |
详情 |
详情
|
(XVI) |
55228 |
N-p-Tosylglycine benzyl ester
|
|
C16H17NO4S |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(IV) The reduction of 4-bromophenylacetic acid (I) with boron hydride gives 2-(4-bromophenyl)ethanol (II), which is mesylated with methanesulfonyl chloride to the sulfonate (III). The condensation of (III) with diethyl malonate (IV) by means of NaH yields 2-[2-(4-bromophenyl)ethyl]malonic acid diethyl ester (V), which is reduced with LiAlH4 to the diol (VI). The enantioselective transesterification of (VI) with methyl acetate by means of porcine pancreatic lipase (PPL, Sigma type II, no. 3126) affords the (R)-enantiomer of monoester (VII), which is treated with tert-butyldimethylsilyl chloride in dichloromethane, giving the (S)-enantiomer of the silylated acetoxy derivative (VIII). The hydrolysis of (VIII) with methanolic NaOH yields the silylated alcohol (IX), which is mesylated with methanesulfonyl chloride as before affording the sulfonate (X). The reaction of (X) with sodium azide in hot DMF gives 1-azido-4-(4-bromophenyl)-2(S)-(tert-butyldimethylsilyloxymethyl)butane (XIII), which is deprotected with acetic acid in THF yielding 2(S)-(azidomethyl)-4-(4-bromophenyl)butanol (XII). Mesylation of (XII) as before affords sulfonate (XIII), which is condensed with diethyl malonate (IV) by means of NaH as before, giving the chiral malonate derivative (XIV). The cyclization of (XIV) by means of tributyl phosphine in THF yields (3RS,5R)-5-[2-(4-bromophenyl)ethyl]-2-oxopiperidine-3-carboxylic acid ethyl ester (XV), which is treated with trimethyloxonium tetrafluoroborate in CHCl3 to afford the methoxy derivative (XVI). Cyclization of (XVI) with guanidine hydrochloride (XXII) by means of sodium ethoxide in hot ethanol gives 2-amino-6(R)-[2-(4-bromophenyl)ethyl]-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine (XVII), which is treated with copper cyanide in refluxing 1-methyl-2-pyrrolidone, yielding the nitrile (XVIII). Hydrolysis of (XVIII) with refluxing 6N HCl affords the corresponding benzoic acid (XIX), which is condensed with L-glutamic acid diethyl ester (XX) by means of N-methylmorpholine and 2-chloro-4,6-dimethoxy-1,3,5-triazine in DMF, affording the diethyl ester of the desired product (XXI). Finally, this compound is hydrolyzed with 1N NaOH.
【1】
Barnett, C.J.; Wilson, T.M. (Eli Lilly and Company); Enantioselective synthesis of antifolates. EP 0417212 .
|
【2】
Barnett, C.J.; Wilson, T.M.; Asymmetric synthesis and absolute configuration of 5,10-dideaza-5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). Tetrahedron Lett 1989, 30, 46, 6291.
|
【3】
Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
|
【4】
Wilson, T.M.; Barnett, C.J.; Asymmetric synthesis and absolute configuration of 5,10-dideaza-5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). Chemistry and Biology of Pteridines (1989): Pteridines and Folic Acid Derivatives. H.-C. Curtius, S. Ghisla and N. Blau (Eds.). de Gruyter, New York 1990, 102. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14247 |
2-(4-Bromophenyl)acetic acid; p-Bromophenylacetic acid; 4-Bromophenylacetic acid
|
1878-68-8 |
C8H7BrO2 |
详情 | 详情
|
(II) |
14248 |
2-(4-Bromophenyl)-1-ethanol; 4-Bromophenethyl alcohol;2-(4-bromophenyl)ethanol;2-(4-Bromophenyl)ethan-1-ol |
4654-39-1 |
C8H9BrO |
详情 | 详情
|
(III) |
14249 |
4-Bromophenethyl methanesulfonate
|
|
C9H11BrO3S |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
14251 |
diethyl 2-(4-bromophenethyl)malonate
|
|
C15H19BrO4 |
详情 |
详情
|
(VI) |
14252 |
2-(4-Bromophenethyl)-1,3-propanediol
|
|
C11H15BrO2 |
详情 |
详情
|
(VII) |
14253 |
(2R)-4-(4-bromophenyl)-2-(hydroxymethyl)butyl acetate
|
|
C13H17BrO3 |
详情 |
详情
|
(VIII) |
14254 |
(2S)-4-(4-bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)butyl acetate
|
|
C19H31BrO3Si |
详情 |
详情
|
(IX) |
14255 |
(2S)-4-(4-Bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-butanol
|
|
C17H29BrO2Si |
详情 |
详情
|
(X) |
14256 |
(2R)-4-(4-bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)butyl methanesulfonate
|
|
C18H31BrO4SSi |
详情 |
详情
|
(XI) |
14257 |
[[(2S)-2-(Azidomethyl)-4-(4-bromophenyl)butyl]oxy](tert-butyl)dimethylsilane; (2S)-2-(Azidomethyl)-4-(4-bromophenyl)butyl tert-butyl(dimethyl)silyl ether
|
|
C17H28BrN3OSi |
详情 |
详情
|
(XII) |
14258 |
(2S)-2-(Azidomethyl)-4-(4-bromophenyl)-1-butanol
|
|
C11H14BrN3O |
详情 |
详情
|
(XIII) |
14259 |
(2S)-2-(azidomethyl)-4-(4-bromophenyl)butyl methanesulfonate
|
|
C12H16BrN3O3S |
详情 |
详情
|
(XIV) |
14260 |
diethyl 2-[(2R)-2-(azidomethyl)-4-(4-bromophenyl)butyl]malonate
|
|
C18H24BrN3O4 |
详情 |
详情
|
(XV) |
14261 |
ethyl (5R)-5-(4-bromophenethyl)-2-oxohexahydro-3-pyridinecarboxylate
|
|
C16H20BrNO3 |
详情 |
详情
|
(XVI) |
14268 |
ethyl (5R)-5-(4-bromophenethyl)-2-methoxy-3,4,5,6-tetrahydro-3-pyridinecarboxylate
|
|
C17H22BrNO3 |
详情 |
详情
|
(XVII) |
14263 |
(6R)-2-Amino-6-(4-bromophenethyl)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-4(3H)-one
|
|
C15H17BrN4O |
详情 |
详情
|
(XVIII) |
14264 |
4-[2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzonitrile
|
|
C16H17N5O |
详情 |
详情
|
(XIX) |
14265 |
4-[2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoic acid
|
|
C16H18N4O3 |
详情 |
详情
|
(XX) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XXI) |
14267 |
diethyl (2S)-2-[(4-[2-[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate
|
|
C25H33N5O6 |
详情 |
详情
|
(XXII) |
14262 |
Guanidine hydrochloride
|
50-01-1 |
CH5N3.HCl |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) Condensation of piperonyl chloride (I) with diethyl malonate (II) by means of Na in anhydrous refluxing EtOH (NaOEt) provides 2-[3,4-(methylenedioxy)benzyl]malonic acid diethyl ester (III), which is converted into the monoethyl ester (IV) by saponification with KOH in EtOH. Treatment of (IV) with diethylamine in paraformaldehyde/H2O affords acrylic ester (V), which is then subjected to saponification with NaOH in acetone/H2O to provide [3,4-(methylenedioxy)benzyl]-2-propenoic acid (VI). Alternatively, derivative (VI) can also be obtained by following this route: treatment of piperonal (VII) with diethyl malonate (II) in refluxing toluene in the presence of piperidine and acetic acid provides diethyl piperonylidene malonate (VIII), which is then hydrogenated over Pd/C to furnish diethyl piperonylmalonate (IX). Saponification of the ethyl ester moiety of (IX) by refluxing with NaOH in H2O affords piperonylmalonic acid (X), which is finally converted into intermediate (VI) by decarboxylation by treatment with diethylamine in refluxing paraformaldehyde. Reaction of (VI) with thioacetic acid at 70 C affords a racemic mixture of propionic acid derivatives (XI), which is resolved by first formation of a chiral salt (either by reaction with (R)-alpha-methylbenzylamine or by reaction with (+)-ephedrine in ether), recrystallization of the corresponding diastereomer and finally liberation of the 2-(S)-(acetylthiomethyl)-3-[3,4-(methylenedioxy)benzyl]propionic acid [(S)-(XII)] by hydrolysis with HCl in H2O/CH2Cl2. Finally, fasidotril is obtained by condensation of (S)-(XII) with benzyl alaninate (XIII) by means of HOBt and DCC in THF/CHCl3 in the presence of Et3N.
【1】
Plaquevent, J.-C.; Danvy, D.; Monteil, T.; Greciet, H.; Duhamel, L.; Duhamel, P.; Gros, C.; Schwartz, J.-C.; Lecomte, J.-M. (Societe Civile Bioprojet); Amino acid derivs., method for their preparation and their therapeutic application. EP 0419327; FR 2652087; WO 9104246 . |
【2】
Lecomte, J.-M.; Duhamel, P.; Danvy, D.; Schwartz, J.-C.; Duhamel, L.; Monteil, T. (Societe Civile Bioprojet); Process for the synthesis of alpha-substd. acrylic acids and their application. EP 0729936 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III),(IX) |
49496 |
diethyl 2-(1,3-benzodioxol-5-ylmethyl)malonate
|
|
C15H18O6 |
详情 |
详情
|
(S)-(XII) |
49501 |
(2S)-3-(acetylsulfanyl)-2-(1,3-benzodioxol-5-ylmethyl)propionic acid
|
|
C13H14O5S |
详情 |
详情
|
(I) |
28617 |
5-(chloromethyl)-1,3-benzodioxole
|
|
C8H7ClO2 |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(IV) |
49497 |
2-(1,3-benzodioxol-5-ylmethyl)-3-ethoxy-3-oxopropionic acid
|
|
C13H14O6 |
详情 |
详情
|
(V) |
38469 |
ethyl (E)-3-(1,3-benzodioxol-5-yl)-2-propenoate
|
|
C12H12O4 |
详情 |
详情
|
(VI) |
11634 |
(E)-3-(1,3-Benzodioxol-5-yl)-2-propenoic acid; 3,4-(Methylenedioxy)cinnamic acid
|
2373-80-0 |
C10H8O4 |
详情 | 详情
|
(VII) |
10127 |
1,3-Benzodioxole-5-carbaldehyde; Heliotropine
|
120-57-0 |
C8H6O3 |
详情 | 详情
|
(VIII) |
49499 |
diethyl 2-(1,3-benzodioxol-5-ylmethylene)malonate
|
|
C15H16O6 |
详情 |
详情
|
(X) |
49500 |
2-(1,3-benzodioxol-5-ylmethyl)malonic acid
|
|
C11H10O6 |
详情 |
详情
|
(XI) |
49498 |
3-(acetylsulfanyl)-2-(1,3-benzodioxol-5-ylmethyl)propionic acid
|
|
C13H14O5S |
详情 |
详情
|
(XIII) |
10143 |
benzyl (2S)-2-aminopropanoate
|
|
C10H13NO2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(IV) The reaction of 3-chloropropanol (I) with 2-methoxypropene (II) by means of PPTS gives the mixed ketal (III), which is condensed with diethyl malonate (IV) by means of sodium ethoxide in hot ethanol, affording the adduct (V). The reduction of (V) with NaH and Red-Al in refluxing toluene provides the allyl alcohol derivative (VI), which is submitted to an asymmetric epoxidation to give the epoxide (VII). The reaction of (VII) with octadecyl bromide (VIII) by means of NaH and tetrabutylammonium iodide (TBAI) yields the corresponding ether (IX), which by reaction with PPTS in HOAc is converted to the tetrahydrofuran-2-methanol derivative (X). Finally, this compound is condensed with POCl3, TEA, choline mesylate (XI) and DMAP in dichloromethane/pyridine to afford the target compound.
【1】
Lohmeyer, M.; Bittman, R.; Antitumor ether lipids and alkylphosphocholines. Drugs Fut 1994, 19, 11, 1021.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
41308 |
2-hydroxy-N,N,N-trimethyl-1-ethanaminium methanesulfonate
|
|
C6H17NO4S |
详情 |
详情
|
(I) |
19490 |
3-chloro-1-propanol
|
627-30-5 |
C3H7ClO |
详情 | 详情
|
(II) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(III) |
41304 |
1-(3-chloropropoxy)-1-methylethyl methyl ether; 1-chloro-3-(1-methoxy-1-methylethoxy)propane
|
|
C7H15ClO2 |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
41309 |
diethyl 2-[3-(1-methoxy-1-methylethoxy)propyl]malonate
|
|
C14H26O6 |
详情 |
详情
|
(VI) |
41305 |
2-[3-(1-methoxy-1-methylethoxy)propyl]-2-propen-1-ol
|
|
C10H20O3 |
详情 |
详情
|
(VII) |
28797 |
1-bromooctadecane
|
112-89-0 |
C18H37Br |
详情 | 详情
|
(VIII) |
41306 |
[(2S)-2-[3-(1-methoxy-1-methylethoxy)propyl]oxiranyl]methyl octadecyl ether; (2S)-2-[3-(1-methoxy-1-methylethoxy)propyl]-2-[(octadecyloxy)methyl]oxirane
|
|
C28H56O4 |
详情 |
详情
|
(IX) |
41307 |
[(2S)-2-[(octadecyloxy)methyl]tetrahydro-2-furanyl]methanol
|
|
C24H48O3 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(IV) The reaction of tetrahydrofuran-2,2-dimethanol (I) with butyryl chloride (II) and Na2CO3 in dichloromethane gives the dibutyrate (III), which is asymmetrized by means of pancreas lipase type II (PPL) or microbial lipase Mucor javanicus (LMJ) yielding the (R)-monobutyrate (IV). The protection of the OH group of (IV) with Tr-Cl and pyridine in dichloromethane affords the trityl ether (V), which is treated with K2CO3 in methanol to provide the chiral carbinol (VI). The reaction of (VI) with benzyl bromide by means of NaH and tetrabutylammonium iodide (TBAI) in refluxing THF gives the corresponding benzyl ether (VII), which is deprotected with TFA in dichloromethane/water to yield the chiral carbinol (VIII). The reaction of (VIII) with octadecyl bromide (IX) by means of NaH and tetrabutylammonium iodide (TBAI) in refluxing THF gives the corresponding octadecyl ether (X), which is debenzylated by hydrogenation with H2 over Pd/C in ethanol to yield the chiral carbinol (XI). Finally, this carbinol is condensed with POCl3, choline tosylate (XII), TEA and pyridine in THF to afford the target compound.
【1】
Prasad, K.; et al.; Asymmetrization of tetrahydrofuran-2,2-dimethanol: Synthesis of the enantiomers of SRI 62-834. J Org Chem 1995, 60, 23, 7693.
|
【2】
Estermann, H.; Houlihan, W.J.; Kapa, P.K.; Underwood, R.L. (Novartis AG; Novartis Deutschland GmbH); Enantiomers of 2-tetrahydrofuran derivs., intermediates therefor and their preparation. EP 0462935; JP 1992270276 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19490 |
3-chloro-1-propanol
|
627-30-5 |
C3H7ClO |
详情 | 详情
|
(II) |
10792 |
Butanoyl chloride; Butyryl chloride
|
141-75-3 |
C4H7ClO |
详情 | 详情
|
(III) |
47575 |
[2-[(butyryloxy)methyl]tetrahydro-2-furanyl]methyl butyrate
|
|
C14H24O5 |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
47577 |
[(2S)-2-[(trityloxy)methyl]tetrahydro-2-furanyl]methyl butyrate
|
|
C29H32O4 |
详情 |
详情
|
(VI) |
47578 |
[(2R)-2-[(trityloxy)methyl]tetrahydro-2-furanyl]methanol
|
|
C25H26O3 |
详情 |
详情
|
(VII) |
47579 |
benzyl [(2R)-2-[(trityloxy)methyl]tetrahydro-2-furanyl]methyl ether; (2R)-2-[(benzyloxy)methyl]-2-[(trityloxy)methyl]tetrahydrofuran
|
|
C32H32O3 |
详情 |
详情
|
(VIII) |
47580 |
[(2S)-2-[(benzyloxy)methyl]tetrahydro-2-furanyl]methanol
|
|
C13H18O3 |
详情 |
详情
|
(IX) |
28797 |
1-bromooctadecane
|
112-89-0 |
C18H37Br |
详情 | 详情
|
(X) |
47581 |
(2R)-2-[(benzyloxy)methyl]-2-[(octadecyloxy)methyl]tetrahydrofuran; benzyl [(2R)-2-[(octadecyloxy)methyl]tetrahydro-2-furanyl]methyl ether
|
|
C31H54O3 |
详情 |
详情
|
(XI) |
41307 |
[(2S)-2-[(octadecyloxy)methyl]tetrahydro-2-furanyl]methanol
|
|
C24H48O3 |
详情 |
详情
|
(XII) |
41265 |
2-hydroxy-N,N,N-trimethyl-1-ethanaminium 4-methylbenzenesulfonate
|
|
C12H21NO4S |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XXXII) Alkylation of potassium phthalimide (XXVII) with epichlorohydrin (XXVIII) provided N-glycidyl phthalimide (XXIX). Epoxide ring opening in (XXIX) with aqueous HBr led to bromohydrin (XXX), which was further oxidized to bromo ketone (XXXI) by means of CrO3. Coupling of bromo ketone (XXXI) with diethyl malonate (XXXII) to afford (XXXIII) was accomplished in the presence of NaOEt in EtOH/DMF as the solvent. Acid hydrolysis of the malonate ester (XXXIII), followed by thermal decarboxylation, gave rise to phthalimido levulinic acid (XI). The phthaloyl group of (XI) was finally hydrolyzed under acidic conditions to furnish delta-aminolevulinic acid.
【1】
Collins, A.; Tschudy, D.P.; Malonic ester synthesis of delta-aminolevulinic acid. The reaction of N-3-bromoacetonylphthalimide with malonic ester. J Org Chem 1959, 24, 556.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
59147 |
5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoic acid
|
|
C13H11NO5 |
详情 |
详情
|
(XXVII) |
27890 |
Potassium phthalimide
|
1074-82-4 |
C8H4KNO2 |
详情 | 详情
|
(XXVIII) |
10246 |
N-Phenyl-2-[(triphenylstannyl)selanyl]benzamide
|
|
C31H25NOSeSn |
详情 |
详情
|
(XXIX) |
12335 |
2-(2-Oxiranylmethyl)-1H-isoindole-1,3(2H)-dione; N-(2,3-Epoxypropyl)phtalimide
|
5455-98-1 |
C11H9NO3 |
详情 | 详情
|
(XXX) |
59158 |
2-(3-bromo-2-hydroxypropyl)-1H-isoindole-1,3(2H)-dione
|
|
C11H10BrNO3 |
详情 |
详情
|
(XXXI) |
59159 |
2-(3-Bromo-2-oxopropyl)isoindole-1,3-dione
|
|
C11H8BrNO3 |
详情 |
详情
|
(XXXII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XXXIII) |
59160 |
diethyl 2-[3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-oxopropyl]malonate
|
|
C18H19NO7 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(I) The condensation of diethyl malonate (I) with (R)-(-)-epichlorohydrin (II) by means of NaOEt in ethanol gives (3aS,4aR)-3-oxo-3,3a,4,4a-tetrahydro-1H-cyclopropa[c]furan-3a-carboxylic acid ethyl ester (III), which is selectively reduced at the lactone group by means of sodium borohydride in ethanol to yield (1R,2R)-1,2-bis(hydroxymethyl)cyclopropanecarboxylic acid ethyl ester (IV). The protection of (IV) with 2,2-dimethoxypropane (V) and Ts-OH in DMF affords the cyclic acetonide (VI), which is reduced with LiBH4 in THF to provide the hydroxymethyl acetonide (VII). The protection of the OH group of (VII) with benzyl bromide and NaH in DMF gives the benzyl ether (VIII), which is treated with HCl in THF/water to cleave the acetonide ring and yield the bis hydroxymethyl compound (IX). The acylation of (IX) with benzoyl chloride and pyridine affords the dibenzoate (X), which is debenzylated with H2 over Pd/C in ethanol/acetic acid to provide (1S,2R)-1,2-bis(benzoyloxymethyl)cyclopropanemethanol (XI). The reaction of (XI) with Ts-OH and DMAP in dichloromethane gives the corresponding tosylate (XII), which is condensed with 6-O-benzylguanine (XIII) by means of K2CO3 in DMF to yield the fully protected nucleoside (XIV). The hydrolysis of the benzoyl group of (XIV) by means of NaOMe in methanol affords the dihydroxy compound (XV), which is finally debenzylated by means of HCl in ethanol/water to provide the target guanine cyclopropyl nucleoside.
【1】
Sekiyama, T.; et al.; Synthesis and antiviral activity of novel acyclic nucleosides: Discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses. J Med Chem 1998, 41, 8, 1284.
|
【2】
Hatsuya, S.; Sekiyama, T.; Tsuji, T.; Iwayama, S.; Okunishi, M. (Ajinomoto Co., Inc.); Cyclopropane deriv.. EP 0502690; JP 1993194421; US 5342840; US 5449840 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
38067 |
(2R)-2-(Chloromethyl)oxirane; (R)-Epichlorohydrin
|
51594-55-9 |
C3H5ClO |
详情 | 详情
|
(III) |
38068 |
ethyl (1S,5R)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate
|
|
C8H10O4 |
详情 |
详情
|
(IV) |
38069 |
ethyl (1R,2R)-1,2-bis(hydroxymethyl)cyclopropanecarboxylate
|
|
C8H14O4 |
详情 |
详情
|
(V) |
10722 |
1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane
|
77-76-9 |
C5H12O2 |
详情 | 详情
|
(VI) |
53924 |
ethyl (1R,7R)-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]octane-1-carboxylate
|
|
C11H18O4 |
详情 |
详情
|
(VII) |
53925 |
[(7R)-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]oct-1-yl]methanol
|
|
C9H16O3 |
详情 |
详情
|
(VIII) |
53926 |
benzyl [(7R)-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]oct-1-yl]methyl ether; (1S,7R)-1-[(benzyloxy)methyl]-4,4-dimethyl-3,5-dioxabicyclo[5.1.0]octane
|
|
C16H22O3 |
详情 |
详情
|
(IX) |
53927 |
[(1R,2R)-2-[(benzyloxy)methyl]-2-(hydroxymethyl)cyclopropyl]methanol
|
|
C13H18O3 |
详情 |
详情
|
(X) |
53928 |
{(1R,2S)-2-[(benzoyloxy)methyl]-2-[(benzyloxy)methyl]cyclopropyl}methyl benzoate
|
|
C27H26O5 |
详情 |
详情
|
(XI) |
53929 |
[(1R,2S)-2-[(benzoyloxy)methyl]-2-(hydroxymethyl)cyclopropyl]methyl benzoate
|
|
C20H20O5 |
详情 |
详情
|
(XII) |
53930 |
[(1R,2R)-2-[(benzoyloxy)methyl]-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)cyclopropyl]methyl benzoate
|
|
C27H26O7S |
详情 |
详情
|
(XIII) |
14383 |
6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine
|
19916-73-5 |
C12H11N5O |
详情 | 详情
|
(XIV) |
53931 |
{(1R,2S)-2-{[2-amino-6-(benzyloxy)-9H-purin-9-yl]methyl}-2-[(benzoyloxy)methyl]cyclopropyl}methyl benzoate
|
|
C32H29N5O5 |
详情 |
详情
|
(XV) |
53932 |
[(1S,2R)-1-{[2-amino-6-(benzyloxy)-9H-purin-9-yl]methyl}-2-(hydroxymethyl)cyclopropyl]methanol
|
n/a |
C18H21N5O3 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(XVIII) 3) The reaction of diethyl malonate (XVIII) with 3-methylbutanal (XIX) by means of dipropylamine in acetic acid gives the corresponding 2-(3-methylbutylidene)malonate derivative (XX), which is treated with KCN to yield the corresponding addition compound (XXI). The decarboxylative hydrolysis of (XXI) with KOH affords 3-cyano-5-methylhexanoic acid (XXII), which is reduced with H2 over Ni to yield racemic pregabalin (XXIII). Finally, this racemate is submitted to optical resolution with (S)-(+)-mandelic acid.
【1】
Bryans, J.S.; Wustrow, D.J.; 3-Substituted GABA analogs with central nervous system activity: A review. Med Res Rev 1999, 19, 2, 149.
|
【2】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【3】
Mulhern, T.; Sobieray, D.M.; Huckabee, B.K.; Grote, T.M.; Titus, R.D. (Pfizer Inc.); Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid. WO 9640617 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XIX) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(XX) |
26053 |
diethyl 2-(3-methylbutylidene)malonate
|
|
C12H20O4 |
详情 |
详情
|
(XXI) |
26054 |
diethyl 2-(1-cyano-3-methylbutyl)malonate
|
|
C13H21NO4 |
详情 |
详情
|
(XXII) |
26055 |
3-cyano-5-methylhexanoic acid
|
|
C8H13NO2 |
详情 |
详情
|
(XXIII) |
26056 |
3-(aminomethyl)-5-methylhexanoic acid
|
130912-52-6 |
C8H17NO2 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) The title compound has been obtained by several related ways:
The reaction of 2-chloro-3-nitropyridine (I) with methylboronic acid by means of Pd(PPh3)4 and K2CO3 in hot dioxane gives 2-methyl-3-nitropyridine (III), which is condensed with dimethylformamide dimethylacetal (IV) to yield 2-[2-(dimethylamino)vinyl]-3-nitropyridine (V). The oxidation of (V) by means of NaIO4 affords 3-nitropyridine-2-carbaldehyde (VI), which is condensed with semicarbazide (VII) to provide the corresponding semicarbazone (VIII). Finally, the nitro group of (VIII) is reduced with SnCl2 or Na2S to furnish the target 3-aminopyridine-2-carbaldehyde semicarbazone.
2-Methyl-3-nitropyridine (III) can also be obtained by condensation of 2-chloro-3-nitropyridine (I) with diethyl malonate (II) by means of Na, followed by decarboxylative hydrolysis with H2SO4 at 125 C.
The direct oxidation of 2-methyl-3-nitropyridine (III) with SeO2 in dioxane gives carbaldehyde (VI), which is treated with ethyleneglycol (IX) and Ts-OH to yield the cyclic acetal (X). The reduction of (X) with H2 over Pd/C in ethanol affords 3-aminopyridine-2-carbaldehyde ethylene ketal (XI), which is treated with semicarbazide (VI) and HCl to afford the target 3-aminopyridine-2-carbaldehyde semicarbazone.
The condensation of 2-chloro-3-nitropyridine (I) with tributyl vinyl tin (XII) Pd(PPh3)4 and PPH3 in refluxing toluene gives 3-nitro-2-vinylpyridine (XIII), which is oxidized with O3 and Me2S in methanol to yield 3-nitropyridine-2-carbaldehyde (VI). This compound is condensed with semicarbazide (VII) and reduced to the target compound as already described.
【1】
Li, J.; et al.; Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-Amino-4-methylpyridine-2-carboxaldehyde-thiosemicarbazone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs. Curr Med Chem 2001, 8, 2, 121. |
【2】
Niu, C.; et al.; Synthesis of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP). Tetrahedron 1998, 54, 23, 6311.
|
【3】
Liu, M-C.; et al.; Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone. J Med Chem 1992, 35, 20, 3672.
|
【4】
Sartorelli, A.C.; Lin, T.-S. (Yale University); 2-Formylpyridine thiosemicarbazone derivs., their preparation and their use as antitumor agents. EP 0570294; JP 1994128230; US 5281715; US 5721259 .
|
【5】
Doyle, T.W.; Li, J.; Chen, S.-H.; Li, X.; Niu, C.-S. (Vion Pharmaceuticals, Inc.); Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP. US 5869676; WO 9851670 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10321 |
2-Chloro-3-nitropyridine
|
5470-18-8 |
C5H3ClN2O2 |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
54410 |
2-methyl-3-nitropyridine
|
18699-87-1 |
C6H6N2O2 |
详情 | 详情
|
(IV) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(V) |
54411 |
(E)-N,N-dimethyl-2-(3-nitro-2-pyridinyl)-1-ethenamine; N,N-dimethyl-N-[(E)-2-(3-nitro-2-pyridinyl)ethenyl]amine
|
|
C9H11N3O2 |
详情 |
详情
|
(VI) |
54414 |
3-nitro-2-pyridinecarbaldehyde
|
10261-94-6 |
C6H4N2O3 |
详情 | 详情
|
(VII) |
12954 |
1-Hydrazinecarbothioamide; Thiosemicarbazide
|
79-19-6 |
CH5N3S |
详情 | 详情
|
(VIII) |
54415 |
2-[(E)-(3-nitro-2-pyridinyl)methylidene]-1-hydrazinecarbothioamide
|
|
C7H7N5O2S |
详情 |
详情
|
(IX) |
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(X) |
54413 |
2-(1,3-dioxolan-2-yl)-3-nitropyridine
|
|
C8H8N2O4 |
详情 |
详情
|
(XI) |
54412 |
2-(1,3-dioxolan-2-yl)-3-pyridinylamine; 2-(1,3-dioxolan-2-yl)-3-pyridinamine
|
|
C8H10N2O2 |
详情 |
详情
|
(XII) |
54417 |
3,3-dibutyl-1-heptene
|
|
C15H30 |
详情 |
详情
|
(XIII) |
54416 |
3-nitro-2-vinylpyridine
|
|
C7H6N2O2 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(XI) The reaction of 3-chlorotetrafluoropyridine (I) with sodium tert-butoxide in THF gives 4-tert-butoxy-3-chloro-2,5,6-trifluoropyridine (II), which is dechlorinated with H2 over Pd/C in methanol yielding 4-tert-butoxy-2,3,6-trifluoropyridine (III). The methylation of (III) with methyl iodide and lithium diethylamide (LDA) in THF affords 4-tert-butoxy-2,3,6-trifluoro-5-methylpyridine (IV), which is selectively defluorinated with hydrazine in refluxing propanol to give 4-tert-butoxy-2,5-difluoro-3-methylpyridine (V). The condensation of (V) with cyclopropylacetonitrile (VI) by means of LDA in THF yields 2-(4-tert-butoxy-5-fluoro-3-methyl-2-pyridyl)-2-cyclopropylacetonitrile (VII), which is treated first with trifluoroacetic acid and then with POCl3 to afford 2-(4-chloro-5-fluoro-3-methyl-2-pyridyl)-2-cyclopropylacetonitrile (VIII). The alcoholysis of (VIII) with ethanol/HCl gives the corresponding ethyl ester (IX), which is partially reduced with LiAlH4 in THF to afford the corresponding aldehyde (X). The condensation of (X) with diethyl malonate (XI) by means of piperidine in refluxing ethanol yields the ethylidenemalonate (XII), which, without isolation, is cyclized by heating at 235 C in Dowtherm to afford 8-chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester (XIII). The reaction of (XIII) with 3(S)-(tert-butoxycarbonylamino)pyrrolidine (XIV) by means of NaHCO3 in acetonitrile gives the corresponding condensation product (XV), which is hydrolyzed ith LiOH in THF/water to the corresponding free acid (XVI). Finally, this compound is deprotected with 4N HCl in dioxandichloromethane.
【1】
Fromtling, R.A.; Castañer, J.; ABT-719. Drugs Fut 1995, 20, 11, 1103.
|
【2】
Chu, D.T.W.; Li, Q.; Claiborne, A.; et al.; Synthesis and antibacterial activity of A-86719.1 and related 2-pyridones: A novel series of potent DNA gyrase inhibitors. 34th Intersci Conf Antimicrob Agents Chemother (Oct 4-7, Orlando) 1994, Abst F41.
|
【3】
Chu, D.T.; Li, Q.; Cooper, C.S.; Fung, A.K.L.; Lee, C.M.; Plattner, J.J. (Abbott Laboratories Inc.); Quinolizinone type cpds. JP 1997503783; WO 9510519 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16819 |
3-chloro-2,4,5,6-tetrafluoropyridine; Pyridine, 3-chloro-2,4,5,6-tetrafluoro-
|
1735-84-8 |
C5ClF4N |
详情 | 详情
|
(II) |
16820 |
4-(tert-butoxy)-3-chloro-2,5,6-trifluoropyridine; tert-butyl 3-chloro-2,5,6-trifluoro-4-pyridinyl ether
|
|
C9H9ClF3NO |
详情 |
详情
|
(III) |
16821 |
4-(tert-butoxy)-2,3,6-trifluoropyridine; tert-butyl 2,3,6-trifluoro-4-pyridinyl ether
|
|
C9H10F3NO |
详情 |
详情
|
(IV) |
16822 |
tert-butyl 2,3,6-trifluoro-5-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,3,6-trifluoro-5-methylpyridine
|
|
C10H12F3NO |
详情 |
详情
|
(V) |
16823 |
tert-butyl 2,5-difluoro-3-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,5-difluoro-3-methylpyridine
|
|
C10H13F2NO |
详情 |
详情
|
(VI) |
16824 |
2-cyclopropylacetonitrile; Cyclopropylacetonitrile
|
6542-60-5 |
C5H7N |
详情 | 详情
|
(VII) |
16825 |
2-[4-(tert-butoxy)-5-fluoro-3-methyl-2-pyridinyl]-2-cyclopropylacetonitrile
|
|
C15H19FN2O |
详情 |
详情
|
(VIII) |
16826 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetonitrile
|
|
C11H10ClFN2 |
详情 |
详情
|
(IX) |
16827 |
ethyl 2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetate
|
|
C13H15ClFNO2 |
详情 |
详情
|
(X) |
16828 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetaldehyde
|
|
C11H11ClFNO |
详情 |
详情
|
(XI) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XII) |
16830 |
diethyl 2-[2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylethylidene]malonate
|
|
C18H21ClFNO4 |
详情 |
详情
|
(XIII) |
16831 |
ethyl 8-chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C16H15ClFNO3 |
详情 |
详情
|
(XIV) |
11685 |
tert-butyl N-[(3S)tetrahydro-1H-pyrrol-3-yl]carbamate
|
|
C9H18N2O2 |
详情 |
详情
|
(XV) |
16833 |
ethyl 8-[(3S)-3-[(tert-butoxycarbonyl)amino]tetrahydro-1H-pyrrol-1-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C25H32FN3O5 |
详情 |
详情
|
(XVI) |
16834 |
8-[(3S)-3-[(tert-butoxycarbonyl)amino]tetrahydro-1H-pyrrol-1-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid
|
|
C23H28FN3O5 |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(I) The reaction of diethyl malonate (I) with (R)-(-)-epichlorohydrin (II) by means of sodium ethoxide in refluxing ethanol gives the 3-oxa-2-oxobicyclic compound (III), which by reduction with NaBH4 in ethanol yields (1S,2R)-1,2-bis(hydroxymethyl)cyclopropanecarboxylic acid ethyl ester (IV). The reaction of (IV) with diphenyldiazomethane by means of 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) in dichloroethane affords (1R,7R)-4,4-diphenyl-3,5-dioxabicyclo[5.1.0]octane-1-carboxylic acid ethyl ester (V), which is reduced with LiBH4 in THF giving the carbinol (VI). The reaction of (VI) with CBr4 and triphenylphosphine in dichloromethane yields the bromomethyl derivative (VII), which is condensed with 5-(2-(E)-bromovinyluracil (VIII) by means of K2CO3 and 18-crown-6 in hot DMF affording the expected addition compound (IX). Finally, this compound is deprotected with HCl in methanol.
【1】
Onishi, T.; Mukai, C.; Sekiyama, T.; Tsuji, T.; Iwayama, S.; Okunishi, M. (Ajinomoto Co., Inc.); Bis(hydroxymethyl)cyclopropylmethyl pyrimidine derivs.,their preparation and their use as anti-viral agents. EP 0649840; JP 1995165731; US 5496824 .
|
【2】
Onishi, T.; Mukai, C.; Nakagawa, R.; et al.; Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety. J Med Chem 2000, 43, 2, 278.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
38067 |
(2R)-2-(Chloromethyl)oxirane; (R)-Epichlorohydrin
|
51594-55-9 |
C3H5ClO |
详情 | 详情
|
(III) |
38068 |
ethyl (1S,5R)-2-oxo-3-oxabicyclo[3.1.0]hexane-1-carboxylate
|
|
C8H10O4 |
详情 |
详情
|
(IV) |
38069 |
ethyl (1R,2R)-1,2-bis(hydroxymethyl)cyclopropanecarboxylate
|
|
C8H14O4 |
详情 |
详情
|
(V) |
38070 |
ethyl (1R,7S)-4,4-diphenyl-3,5-dioxabicyclo[5.1.0]octane-1-carboxylate
|
|
C21H22O4 |
详情 |
详情
|
(VI) |
38071 |
[(7S)-4,4-diphenyl-3,5-dioxabicyclo[5.1.0]oct-1-yl]methanol
|
|
C19H20O3 |
详情 |
详情
|
(VII) |
38072 |
(1R,7S)-1-(bromomethyl)-4,4-diphenyl-3,5-dioxabicyclo[5.1.0]octane
|
|
C19H19BrO2 |
详情 |
详情
|
(VIII) |
38073 |
5-[(E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
|
69304-49-0 |
C6H5BrN2O2 |
详情 | 详情
|
(IX) |
38074 |
5-[(E)-2-bromoethenyl]-1-[[(7S)-4,4-diphenyl-3,5-dioxabicyclo[5.1.0]oct-1-yl]methyl]-2,4(1H,3H)-pyrimidinedione
|
|
C25H23BrN2O4 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(XVI) Intermediate (VII) can be obtained by following two different pathways:
1. Hydrogenation of 4-pyridine acetic acid (IX) over PtO2 in AcOH affords piperidinyl derivative (X), which is then protected with Boc2O and NaOH in THF to yield (XI). Reduction of the CO2H group of (XI) with BH3.THF in THF gives alcohol (XII), which is then subjected to Swern oxidation with oxalyl chloride and DMSO in CH2Cl2, followed by reaction with Wittig reagent (XIII) and N-methyl morpholine (NMM), to provide crotonate (XIV). Hydrogenation of (XIV) over Pd/C in MeOH furnishes methyl butyrate (XV), which is finally hydrolyzed with NaOH in MeOH.
2. Alternatively, intermediate (VII) can be obtained by reaction of diethyl malonate (XVI) with 4-vinylpyridine and NaH in EtOH to afford derivative (XVIII), which is hydrolyzed and decarboxylated with HCl/H2O and then hydrogenated over PtO2 to provide piperidine derivative (XIX). Finally, (XIX) is protected by reaction with Boc2O and NaOH in THF.
【1】
Molino, B.F.; Klein, S.I.; Czekaj, M.; et al.; Design of a new class of orally active fibrinogen receptor antagonists. J Med Chem 1998, 41, 14, 2492.
|
【2】
Klein, S.I.; Molino, B.F. (Aventis Pharma SA); Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides. EP 0812205; JP 1997507213; US 5866685; WO 9510295 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
45852 |
4-[1-(tert-butoxycarbonyl)-4-piperidinyl]butyric acid
|
|
C14H25NO4 |
详情 |
详情
|
(IX) |
17883 |
2-(4-pyridinyl)acetic acid
|
28356-58-3 |
C7H7NO2 |
详情 | 详情
|
(X) |
45854 |
2-(4-piperidinyl)acetic acid; 4-piperidinylacetic acid
|
51052-78-9 |
C7H13NO2 |
详情 | 详情
|
(XI) |
19346 |
1-Boc-piperidin-4-ylacetic acid; 2-[1-(tert-butoxycarbonyl)-4-piperidinyl]acetic acid
|
157688-46-5 |
C12H21NO4 |
详情 | 详情
|
(XII) |
43453 |
tert-butyl 4-(2-hydroxyethyl)-1-piperidinecarboxylate
|
|
C12H23NO3 |
详情 |
详情
|
(XIII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XIV) |
45855 |
tert-butyl 4-[(E)-4-methoxy-4-oxo-2-butenyl]-1-piperidinecarboxylate
|
|
C15H25NO4 |
详情 |
详情
|
(XV) |
45856 |
tert-butyl 4-(4-methoxy-4-oxobutyl)-1-piperidinecarboxylate
|
|
C15H27NO4 |
详情 |
详情
|
(XVI) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XVII) |
45857 |
4-vinylpyridine
|
|
C7H7N |
详情 |
详情
|
(XVIII) |
45858 |
diethyl 2-[2-(4-pyridinyl)ethyl]malonate
|
|
C14H19NO4 |
详情 |
详情
|
(XIX) |
45859 |
4-(4-piperidinyl)butyric acid
|
|
C9H17NO2 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(X) Synthesis of intermediate (XX):
The reaction of 2-chloro-2',4'-difluoroacetophenone (I) with sodium acetate and NaI in DMF gives 2-acetoxy-2',4'-difluoroacetophenone (II), which by methylenation with methyltriphenylphosphonium bromide and sodium bis(trimethylsilyl)amide in THF yields 2-(2,4-difluorophenyl)-2-propen-1-ol acetate ester (III). The hydrolysis of (III) with KOH in dioxane/water affords the corresponding alcohol (IV), which is regioselectively epoxidized with titanium tetraisopropoxide and L-(+)-diethyl tartrate in dichloromethane to (S)-(-)-2-(2,4-difluorophenyl)oxirane-2-methanol (V). The reaction of (V) with 1,2,4-triazole (VI) in DMF affords (R)-2-(2,4-difluorophenyl)-3-(1,2,4-triazol-1-yl)propane-1,2-diol (VII), which is selectively mesylated with methanesulfonyl chloride and triethylamine to the monomesylate (VIII). The cyclization of (VIII) with NaH in DMF gives the oxirane (IX), which is condensed with diethyl malonate (X) by means of NaH in DMSO to yield a mixture of (5R-cis)- and (5R-trans)-5-(2,4-difluorophenyl)-2-oxo-5-(1,2,4-triazol-1-ylmethyl) tetrahydrofuran-3-carboxylic acid ethyl ester (XI). The reduction of (XI) with NaBH4 and LiCl in ethanol affords (R)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)-5-(1,2,4-triazol-1-yl) pentane-1,4-diol (XII), which is selectively tosylated with tosyl chloride and triethylamine in THF to the bistosylate (XIII). The cyclization of (XIII) by means of NaH in refluxing toluene gives (5R-cis)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl) tetrahydrofuran-3-methanol tosylate ester (XIV). The reaction of (XIV) with 1-(4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine (XV) to obtain compound (XVI), and the following reaction sequence (XVI) to (XVII) to (XVIII) to (XIX) to (5R-cis)-4-[4-[4-[4-[5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-ylmethoxy]phenyl]piperazin-1-yl]phenyl-3,4-dihydro-2H-1,2,4-triazol-3-one (XX) has been performed according to J Med Chem 1984, 27: 894-900.
【1】
Fromtling, R.A.; Castañer, J.; SCH-56592. Drugs Fut 1996, 21, 2, 160.
|
【2】
Saksena, A.K.; Girijavallabhan, V.M.; Lovey, R.G.; Pike, R.E.; Wang, H.; Liu, Y.-T.; Ganguly, A.K.; Bennett, F. (Schering Corp.); Tetrahydrofuran antifungals. EP 0736030; JP 1997500658; US 5661151; US 5703079; WO 9517407 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16321 |
2-Chloro-2',4'-difluoroacetophenone; 2-Chloro-1-(2,4-difluorophenyl)-1-ethanone
|
51336-94-8 |
C8H5ClF2O |
详情 | 详情
|
(II) |
16322 |
2-(2,4-Difluorophenyl)-2-oxoethyl acetate
|
|
C10H8F2O3 |
详情 |
详情
|
(III) |
16323 |
2-(2,4-difluorophenyl)-2-propenyl acetate
|
|
C11H10F2O2 |
详情 |
详情
|
(IV) |
15491 |
2-(2,4-difluorophenyl)-2-propen-1-ol
|
|
C9H8F2O |
详情 |
详情
|
(V) |
17058 |
[(2S)-2-(2,4-difluorophenyl)oxiranyl]methanol
|
|
C9H8F2O2 |
详情 |
详情
|
(VI) |
13135 |
1H-1,2,4-Triazole; 1,2,4-Triazole
|
288-88-0 |
C2H3N3 |
详情 | 详情
|
(VII) |
16327 |
(2R)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol
|
|
C11H11F2N3O2 |
详情 |
详情
|
(VIII) |
17061 |
(2R)-2-(2,4-difluorophenyl)-1-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]-3-(1H-1,2,4-triazol-1-yl)-2-propanol
|
|
C14H17F2N3O2S |
详情 |
详情
|
(IX) |
15477 |
1-[[(2R)-2-(2,4-difluorophenyl)oxiranyl]methyl]-1H-1,2,4-triazole
|
|
C11H9F2N3O |
详情 |
详情
|
(X) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XI) |
16331 |
ethyl (5R)-5-(2,4-difluorophenyl)-2-oxo-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furancarboxylate
|
|
C16H15F2N3O4 |
详情 |
详情
|
(XII) |
16332 |
(4R)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)-5-(1H-1,2,4-triazol-1-yl)-1,4-pentanediol
|
|
C14H17F2N3O3 |
详情 |
详情
|
(XIII) |
17066 |
(4R)-4-(2,4-difluorophenyl)-4-hydroxy-2-([[(4-methylphenyl)sulfonyl]oxy]methyl)-5-(1H-1,2,4-triazol-1-yl)pentyl 4-methylbenzenesulfonate
|
|
C28H29F2N3O7S2 |
详情 |
详情
|
(XIV) |
16311 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-methylbenzenesulfonate
|
|
C21H21F2N3O4S |
详情 |
详情
|
(XV) |
16345 |
4-[4-(4-nitrophenyl)piperazino]phenol
|
|
C16H17N3O3 |
详情 |
详情
|
(XVI) |
16347 |
[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-[4-(4-nitrophenyl)-1-piperazinyl]phenyl ether
|
|
C30H30F2N6O4 |
详情 |
详情
|
(XVII) |
17070 |
4-[4-(4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methoxy]phenyl)-1-piperazinyl]phenylamine
|
|
C30H32F2N6O2 |
详情 |
详情
|
(XVIII) |
17071 |
N-[4-[4-(4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methoxy]phenyl)-1-piperazinyl]phenyl]-N-(1-phenoxyvinyl)amine
|
|
C38H38F2N6O3 |
详情 |
详情
|
(XIX) |
16350 |
N-[4-[4-(4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methoxy]phenyl)-1-piperazinyl]phenyl]-1-hydrazinecarboxamide
|
|
C31H34F2N8O3 |
详情 |
详情
|
(XX) |
16351 |
4-[4-[4-(4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methoxy]phenyl)-1-piperazinyl]phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C32H32F2N8O3 |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(X) 2) The 2-(2,4-difluorophenyl)-2-propen-1-ol (IV) is converted into the corresponding propenyl bromide (XXVI), which is condensed with diethyl malonate (X) to afford the malonyl derivative (XXVII). The reduction of (XXVII) with NaBH4 and LiCl yields the 1,3-propanediol derivative (XXVIII), which is enantioselectively acetylated with vinyl acetate and Novozyme 435 in acetonitrile yielding the isomeric (S)-monoacetate (XXIX). The cyclization of (XXIX) with iodine and NaHCO3 in acetonitrile affords (5R-cis)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydrofuran-3-methanol acetate ester (XXX), which is condensed with sodium 1,2,4-triazole (XXXI) to give (5R-cis)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl) tetrahydrofuran-3-methanol acetate ester (XXXII). The hydrolysis of (XXXII) with NaOH yields the corresponding methanol (XXXIII), which is finally tosylated to the tosyl ester (XIV), already obtained previously.
【1】
Saksena, A.K.; Girijavallabhan, V.M.; Lovey, R.G.; Bennett, F.; Pike, R.E.; Wang, H.; Pinto, P.; Liu, Y.T.; Patel, N.; Ganguly, A.K.; Novel analogs of SCH 51048: Synthesis and preliminary structure activity relationships. 35th Intersci Conf Antimicrob Agents Chemother (Sept 17-20, San Francisco) 1995, Abst F83.. |
【2】
Fromtling, R.A.; Castañer, J.; SCH-56592. Drugs Fut 1996, 21, 2, 160.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
24543 |
vinyl acetate
|
108-05-4 |
C4H6O2 |
详情 | 详情
|
(IV) |
15491 |
2-(2,4-difluorophenyl)-2-propen-1-ol
|
|
C9H8F2O |
详情 |
详情
|
(X) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XXVI) |
16335 |
1-[1-(bromomethyl)vinyl]-2,4-difluorobenzene
|
|
C9H7BrF2 |
详情 |
详情
|
(XXVII) |
16337 |
diethyl 2-[2-(2,4-difluorophenyl)-2-propenyl]malonate
|
|
C16H18F2O4 |
详情 |
详情
|
(XXVIII) |
16338 |
2-[2-(2,4-difluorophenyl)-2-propenyl]-1,3-propanediol
|
|
C12H14F2O2 |
详情 |
详情
|
(XXIX) |
16339 |
(2S)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-pentenyl acetate
|
|
C14H16F2O3 |
详情 |
详情
|
(XXX) |
16340 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydro-3-furanyl]methyl acetate
|
|
C14H15F2IO3 |
详情 |
详情
|
(XXXI) |
13104 |
1,2,4-Triazole, sodium derivative
|
41253-21-8 |
C2H2N3Na |
详情 | 详情
|
(XXXII) |
16342 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl acetate
|
|
C16H17F2N3O3 |
详情 |
详情
|
(XXXIII) |
16343 |
[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methanol
|
|
C14H15F2N3O2 |
详情 |
详情
|
合成路线29
该中间体在本合成路线中的序号:
(IV) Nitration of 2,4,5-trifluoro-3-methylbenzoic acid (I) with H2SO4 and HNO3 provides nitrobenzoic acid derivative (II), which is then converted into the nitrobenzoyl chloride derivative (III) by reaction with oxalyl chloride in CH2Cl2 in the presence of DMF.
Condensation of (III) with diethyl malonate (IV) by means of Mg in EtOH in the presence of CCl4 yields diethyl (2,4,5-trifluoro-3-methyl-6-nitrobenzoyl)malonate (V), which is then treated with p-toluene sulfonic acid in refluxing H2O to furnish ethyl acetate derivative (VI). Reaction of (VI) with ethyl orthoformate and acetic anhydride at reflux affords ethyl acrylate derivative (VII), which is then treated with cyclopropylamine (VIII) in EtOH to give compound (IX). Cyclization of (IX) is then induced either by treatment with NaH in 1,4-dioxane or with 18-crown-6-ether and K2CO3 in THF to provide quinolone derivative (X), whose nitro group is reduced by hydrogenation over Ni Raney in HOAc to give amino derivative (XI). Hydrolysis of the ethyl ester moiety of (XI) is performed by refluxing with HCl/HOAc to furnish carboxylic acid (XII), which is then treated with boron trifluoride etherate to give boron chelate (XIII). Finally, condensation of (XIII) with (S)-7-trifluoroacetylamino-5-azaspiro[2.4]heptane hydrochloride (XIV) by means of Et3N in DMSO, followed by deprotection with KOH in H2O and treatment with MeSO3H affords the desired compound.
Alternatively, the target product can also be synthesized from the Boc protected derivative (XVI) obtained either by coupling of boron chelate (XIII) with (S)-7-Boc-amino-5-azaspiro[2.4]heptane hydrochloride (XIV) by means of DIEA in DMSO (or Et3N in MeOH) or by reaction between carboxylic acid (XII) and compound (XV) by heating in DMSO. Finally, the Boc protecting group of (XVI) is removed with HCl and the corresponding methanesulfonate salt formed by treatment with MeSO3H.
【1】
Yoshida, T.; et al.; Studies on quinolone antibacterials.V. Synthesis and antibacterial activity of chiral 5-amino-7-(4-substituted-3-amino-1-pyrrolidinyl)-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acids and derivatives. Chem Pharm Bull 1996, 44, 7, 1376. |
【2】
Ito, Y.; Kato, H.; Yasuda, S.; Kado, N.; Yoshida, T.; Yamamoto, Y. (Hokuriku Seiyaku Co., Ltd.); 5-Amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid deriv.. CA 2126118; EP 0641793; JP 1995309864; US 5547962 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51094 |
2,4,5-trifluoro-3-methylbenzoic acid
|
|
C8H5F3O2 |
详情 |
详情
|
(II) |
51095 |
2,4,5-trifluoro-3-methyl-6-nitrobenzoic acid
|
|
C8H4F3NO4 |
详情 |
详情
|
(III) |
51096 |
2,4,5-trifluoro-3-methyl-6-nitrobenzoyl chloride
|
|
C8H3ClF3NO3 |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
51097 |
diethyl 2-(2,4,5-trifluoro-3-methyl-6-nitrobenzoyl)malonate
|
|
C15H14F3NO7 |
详情 |
详情
|
(VI) |
51098 |
ethyl 3-oxo-3-(2,4,5-trifluoro-3-methyl-6-nitrophenyl)propanoate
|
|
C12H10F3NO5 |
详情 |
详情
|
(VII) |
51099 |
ethyl (Z)-3-ethoxy-2-(2,4,5-trifluoro-3-methyl-6-nitrobenzoyl)-2-propenoate
|
|
C15H14F3NO6 |
详情 |
详情
|
(VIII) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(IX) |
51100 |
ethyl (Z)-3-(cyclopropylamino)-2-(2,4,5-trifluoro-3-methyl-6-nitrobenzoyl)-2-propenoate
|
|
C16H15F3N2O5 |
详情 |
详情
|
(X) |
51101 |
ethyl 1-cyclopropyl-6,7-difluoro-8-methyl-5-nitro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H14F2N2O5 |
详情 |
详情
|
(XI) |
51102 |
ethyl 5-amino-1-cyclopropyl-6,7-difluoro-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H16F2N2O3 |
详情 |
详情
|
(XII) |
51103 |
5-amino-1-cyclopropyl-6,7-difluoro-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C14H12F2N2O3 |
详情 |
详情
|
(XIII) |
51104 |
|
|
C14H11BF4N2O3 |
详情 |
详情
|
(XIV) |
51105 |
N-[(7S)-5-azaspiro[2.4]hept-7-yl]-2,2,2-trifluoroacetamide
|
|
C8H11F3N2O |
详情 |
详情
|
(XV) |
15193 |
tert-butyl N-[(7S)-5-azaspiro[2.4]hept-7-yl]carbamate
|
|
C11H20N2O2 |
详情 |
详情
|
(XVI) |
51106 |
5-amino-7-[(7S)-7-[(tert-butoxycarbonyl)amino]-5-azaspiro[2.4]hept-5-yl]-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C25H31FN4O5 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
Reductive ring closure of diethyl 2-nitrobenzylidenemalonate (I) afforded quinolone (II). Subsequent N-alkylation of (II) with isopropyl iodide gave (III). Carboxylic acid (IV) was then obtained by basic hydrolysis of the ethyl ester (III). In a related procedure, reductive alkylation of 2-aminobenzyl alcohol (V) with acetone in the presence of NaBH4 gave the N-isopropyl derivative (VI). Oxidation of (VI) using activated MnO2 in toluene yielded aldehyde (VII). Further Knoevenagel condensation of (VII) with diethyl malonate in the presence of piperidine and AcOH produced the previously described quinolone ester (III). Alternatively, condensation of (VII) with malonic acid directly produced the previously described quinolonecarboxylic acid (IV). Acid chloride (VIII) was then prepared by treatment of (IV) with thionyl chloride in hot toluene.
【1】
Yokomori, S.; Muramatsu, M.; Suzuki, M.; Ito, C.; Asanuma, H.; Isobe, Y.; Ohuchi, Y.; Kaneko, T.; Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as potent and selective serotonin 5-HT4 receptor agonists. Chem Pharm Bull 2001, 49, 1, 29. |
【2】
Ohuchi, Y.; Suzuki, M.; Asanuma, H.; Yokomori, S.; Hatayama, K. (Taisho Pharmaceutical Co., Ltd.); Quinolinecarboxylic acid deriv.. EP 0710662; JP 1996034784; US 5753673; WO 9531455 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(I) |
36330 |
diethyl 2-(2-nitrobenzylidene)malonate
|
|
C14H15NO6 |
详情 |
详情
|
(II) |
36331 |
ethyl 2-oxo-1,2-dihydro-3-quinolinecarboxylate
|
|
C12H11NO3 |
详情 |
详情
|
(III) |
36332 |
ethyl 1-isopropyl-2-oxo-1,2-dihydro-3-quinolinecarboxylate
|
|
C15H17NO3 |
详情 |
详情
|
(IV) |
36333 |
1-isopropyl-2-oxo-1,2-dihydro-3-quinolinecarboxylic acid
|
|
C13H13NO3 |
详情 |
详情
|
(V) |
18619 |
(2-aminophenyl)methanol; 2-Amino-benzenemethanol;2-Hydroxymethyl aniline;2-aminobenzyl alcohol;o-Aminobenzyl 2-aminobenzylalcohol;alcohol; 2-aminobenzenemethanol; 2-aminobenzyl alcohol |
5344-90-1 |
C7H9NO |
详情 | 详情
|
(VI) |
36334 |
[2-(isopropylamino)phenyl]methanol;2-(isopropylamino)benzyl alcohol;(2-(isopropylamino)phenyl)methanol |
|
C10H15NO |
详情 |
详情
|
(VII) |
36335 |
2-(isopropylamino)benzaldehyde
|
|
C10H13NO |
详情 |
详情
|
(VIII) |
36336 |
1-isopropyl-2-oxo-1,2-dihydro-3-quinolinecarbonyl chloride
|
|
C13H12ClNO2 |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
The reaction of 2,6-dichloropyridine (I) with BuLi and CO2 in THF gives 2,6-dichloropyridine-3-carboxylic acid (II) (1), which by reaction with refluxing SOCl2 yields the acyl chloride (III). The reaction of (III) with malonic ester by means of magnesium ethoxide in ethyl ether affords the nicotinoylacetic ester (IV), which is condensed with thiazol-2-amine (V) and triethylorthoformate by means of acetic anhydride providing the nicotinoyl acrylate (VI). The cyclization of (VI) by means of K2CO3 in hot dioxane gives the 7-chloro-4-oxo-1-(2-thiazolyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid ethyl ester (VII), which is condensed with the chiral pyrrolidine (VIII) by means of triethylamine yielding the proteted intermediate (IX). Finally, this compound is deprotected and hydrolyzed with hot aqueous HCl.
【1】
Tomita, K.; et al.; Synthesis and antitumor activity of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 249.
|
【2】
Tomita, K.; Chiba, K.; Kashimoto, S.; Shibamori, K.; Tsuzuki, Y. (Dainippon Pharmaceutical Co., Ltd.); Novel cpd., process for producing the same, and antitumor agent. EP 0787726; US 5817669; WO 9534559 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(I) |
13573 |
2,6-Dichloropyridine
|
2402-78-0 |
C5H3Cl2N |
详情 | 详情
|
(II) |
26644 |
2,6-dichloronicotinic acid
|
38496-18-3 |
C6H3Cl2NO2 |
详情 | 详情
|
(III) |
26645 |
2,6-dichloronicotinoyl chloride
|
|
C6H2Cl3NO |
详情 |
详情
|
(IV) |
26646 |
ethyl 3-(2,6-dichloro-3-pyridinyl)-3-oxopropanoate
|
|
C10H9Cl2NO3 |
详情 |
详情
|
(V) |
19795 |
2-Thiazolamine; 1,3-thiazol-2-amine; 1,3-thiazol-2-ylamine
|
96-50-4 |
C3H4N2S |
详情 | 详情
|
(VI) |
26647 |
ethyl (Z)-2-[(2,6-dichloro-3-pyridinyl)carbonyl]-3-(1,3-thiazol-2-ylamino)-2-propenoate
|
|
C14H11Cl2N3O3S |
详情 |
详情
|
(VII) |
26648 |
ethyl 7-chloro-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro[1,8]naphthyridine-3-carboxylate
|
|
C14H10ClN3O3S |
详情 |
详情
|
(VIII) |
26649 |
tert-butyl (3S,4S)-4-methoxypyrrolidinyl(methyl)carbamate
|
|
C11H22N2O3 |
详情 |
详情
|
(IX) |
26650 |
ethyl 7-[(3S,4S)-3-[(tert-butoxycarbonyl)(methyl)amino]-4-methoxypyrrolidinyl]-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro[1,8]naphthyridine-3-carboxylate
|
|
C25H31N5O6S |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(II) The condensation of 2,4,5-trifluoro-3-methoxybenzoyl chloride (I) with 14C-labeled diethyl malonate (II) by means of MgCl2 and TEA gives the benzoylmalonate (III), which is monodecarboxylated with TsOH in refluxing water, yielding the benzoylacetate (IV). The reaction of (IV) with triethyl orthoformate and Ac2O at 140 C affords the benzoylacrylate (V), which is treated with cyclopropylamine (VI) in cyclohexane to provide ethyl 3-(cyclopropylamino)-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate (VII). The cyclization of (VII) by means of K2CO3 in hot N-methylpyrrolidone gives the quinolone carboxylate (VIII), which is hydrolyzed with NaOH in hot methanol, affording the carboxylic acid (IX). Finally, this compound is condensed with (S,S)-2,8-diazabicyclo[4.3.0]octane (X) by means of 1,4-diazabicyclo[2.2.2]octane (DABCO) in refluxing acetonitrile.
【1】
Seidel, D.; Conrad, M.; Brehmer, P.; Mohrs, K.; Petersen, U.; Synthesis of carbon-14 labelled moxifloxacin hydrochloride. J Label Compd Radiopharm 2000, 43, 8, 795.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12259 |
2,4,5-Trifluoro-3-methoxybenzoyl chloride
|
|
C8H4ClF3O2 |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
45330 |
diethyl malonate
|
|
C7H12O4 |
详情 |
详情
|
(III) |
12260 |
diethyl 2-(2,4,5-trifluoro-3-methoxybenzoyl)malonate
|
|
C15H15F3O6 |
详情 |
详情
|
(III) |
45331 |
diethyl 2-(2,4,5-trifluoro-3-methoxybenzoyl)malonate
|
|
C15H15F3O6 |
详情 |
详情
|
(IV) |
12261 |
ethyl 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate
|
|
C12H11F3O4 |
详情 |
详情
|
(IV) |
45332 |
ethyl 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate
|
|
C12H11F3O4 |
详情 |
详情
|
(V) |
12262 |
ethyl (Z)-3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)-2-propenoate
|
|
C15H15F3O5 |
详情 |
详情
|
(V) |
45333 |
ethyl (Z)-3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)-2-propenoate
|
|
C15H15F3O5 |
详情 |
详情
|
(VI) |
12263 |
Cyclopropylamine; Cyclopropanamine
|
765-30-0 |
C3H7N |
详情 | 详情
|
(VII) |
12264 |
ethyl (E)-3-(cyclopropylamino)-2-(2,4,5-trifluoro-3-methoxybenzoyl)-2-propenoate
|
|
C16H16F3NO4 |
详情 |
详情
|
(VII) |
45334 |
ethyl (Z)-3-(cyclopropylamino)-2-(2,4,5-trifluoro-3-methoxybenzoyl)-2-propenoate
|
|
C16H16F3NO4 |
详情 |
详情
|
(VIII) |
12265 |
ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H15F2NO4 |
详情 |
详情
|
(VIII) |
45335 |
ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C16H15F2NO4 |
详情 |
详情
|
(IX) |
12266 |
1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
112811-72-0 |
C14H11F2NO4 |
详情 | 详情
|
(IX) |
45336 |
1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C14H11F2NO4 |
详情 |
详情
|
(X) |
17253 |
(4aS,7aS)octahydro-1H-pyrrolo[3,4-b]pyridine
|
|
C7H14N2 |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(IX) 2-Methoxynaphthalene (I) was condensed with bis(N-phenyl-chloromethylimine) (II) using AlCl3 to give 3-methoxyacenaphthene-quinone (III), which was oxidized with H2O2 to afford the naphthalic anhydride (IV). After acid hydrolysis of (IV) and methylation with dimethyl sulfate, the resulting diester (V) was reduced with LiAlH4 to yield diol (VI), which was transformed into dibromide (VII) by means of PBr3. Condensation of (VII) with diethyl malonate (VIII) provided the phenalene dicarboxylate ester (IX). Then, basic hydrolysis of (IX) followed by decarboxylation of the diacid furnished the phenalene-2-carboxylic acid (X). Amine (XIV) was obtained from acid (X) by formation of the acyl azide (XII) through the mixed anhydride (XI), followed by Curtius rearrangement to the corresponding isocyanate (XIII) and acid hydrolysis. Finally, amine (XIV) was acetylated with acetic anhydride to provide the target acetamide.
【1】
Jellimann, C.; et al.; Melatonergic properties of the (+)- and (-)-enanti. J Med Chem 1999, 42, 6, 1100.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23645 |
methyl 2-naphthyl ether; 2-methoxynaphthalene
|
93-04-9 |
C11H10O |
详情 | 详情
|
(II) |
23646 |
2-chloro-N-phenyl-2-(phenylimino)ethanimidoyl chloride
|
|
C14H10Cl2N2 |
详情 |
详情
|
(III) |
23647 |
3-methoxyacenaphthoquinone
|
|
C13H8O3 |
详情 |
详情
|
(IV) |
23648 |
4-methoxy-1H,3H-benzo[de]isochromene-1,3-dione
|
|
C13H8O4 |
详情 |
详情
|
(V) |
23649 |
dimethyl 2-methoxy-1,8-naphthalenedicarboxylate
|
|
C15H14O5 |
详情 |
详情
|
(VI) |
23650 |
[8-(hydroxymethyl)-2-methoxy-1-naphthyl]methanol
|
|
C13H14O3 |
详情 |
详情
|
(VII) |
23651 |
1,8-bis(bromomethyl)-2-naphthyl methyl ether; 1,8-bis(bromomethyl)-2-methoxynaphthalene
|
|
C13H12Br2O |
详情 |
详情
|
(IX) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(IX) |
23653 |
diethyl 4-methoxy-1H-phenalene-2,2(3H)-dicarboxylate
|
|
C20H22O5 |
详情 |
详情
|
(X) |
23654 |
4-methoxy-2,3-dihydro-1H-phenalene-2-carboxylic acid
|
|
C15H14O3 |
详情 |
详情
|
(XI) |
23655 |
4-Methoxy-2,3-dihydro-1H-phenalene-2-carboxylic acid ethoxycarbonyl anhydride
|
|
C18H18O5 |
详情 |
详情
|
(XII) |
23656 |
4-methoxy-2,3-dihydro-1H-phenalene-2-carbonyl azide
|
|
C15H13N3O2 |
详情 |
详情
|
(XIII) |
23657 |
4-methoxy-2,3-dihydro-1H-phenalen-2-yl isocyanate; 2-isocyanato-4-methoxy-2,3-dihydro-1H-phenalene
|
|
C15H13NO2 |
详情 |
详情
|
(XIV) |
23658 |
4-methoxy-2,3-dihydro-1H-phenalen-2-amine; 4-methoxy-2,3-dihydro-1H-phenalen-2-ylamine
|
|
C14H15NO |
详情 |
详情
|
合成路线34
该中间体在本合成路线中的序号:
(II) The condensation of 3,4-dimethylbenzyl chloride (I) with diethyl malonate (II) by means of sodium ethoxide ethanol gives the diethyl 2-(3,4-dimethylbenzyl)malonate (III), which by treatment with aqueous refluxing NaOH and the with refluxing aqueous sulfuric acid yields 3-(3,4-dimethylphenyl)propionic acid (IV). The reaction of (IV) with refluxing SOCl2 affords the corresponding acyl chloride (V), which is treated with ammonia providing the amide (VI). The reduction of (VI) with LiAlH4 in refluxing THF gives 3-(3,4-dimethylphenyl)propylamine (VII), which by condensation with 2-(4-hydroxy-3-methoxyphenyl)acetic acid (VIII) by heating at 150 C yields the corresponding amide (IX). The alkylation of the phenolic group of (IX) with 1,2-dibromoethane (X) and NaH in refluxing THF affords the 2-bromoethoxy derivative (XI), which by treatment with NaN3 and Bu4NBr in refluxing benzene gives the 2-azidoethoxy derivative (XII). Finally, this compound is reduced with H2 over Pd/C in ethyl acetate to afford the target compound.
【1】
Lee, J.-C.; Lee, K.-S.; Han, M.-S.; Jung, Y.S.; Choi, J.; Park, N.-S.; Ha, D.-C.; Seong, C.-M.; Lim, H.-J.; Choi, S.W.; Synthesis of homovanillic amide derivatives and their analgesic activity. Arch Pharmacal Res 1996, 19, 3, 246.
|
【2】
Lim, H.-J.; Park, N.-S.; Choi, J.-K.; Ha, D.-C.; Kim, H.-S.; Lee, B.-Y.; N-Aralkylated 4-(2-aminoethoxy)phenylacetamide derivatives as potent analgesic and antiinflammatory agents. Korean Journal of Medicinal Chemistry 1991, 1, 1, 36.
|
【3】
Lee, K.S.; Choi, J.K.; Hong, M.S.; Kim, H.S.; Lim, H.J.; Ha, D.C.; Park, N.S. (Korea Research Institute of Chemical Technology); Novel phenylacetamide derivs. and processes for the preparation thereof. EP 0525360; US 5242944 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40283 |
4-(chloromethyl)-1,2-dimethylbenzene
|
102-46-5 |
C9H11Cl |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
40284 |
diethyl 2-(3,4-dimethylbenzyl)malonate
|
|
C16H22O4 |
详情 |
详情
|
(IV) |
40285 |
3-(3,4-dimethylphenyl)propionic acid
|
|
C11H14O2 |
详情 |
详情
|
(V) |
40286 |
3-(3,4-dimethylphenyl)propanoyl chloride
|
|
C11H13ClO |
详情 |
详情
|
(VI) |
40287 |
3-(3,4-dimethylphenyl)propanamide
|
|
C11H15NO |
详情 |
详情
|
(VII) |
40288 |
3-(3,4-dimethylphenyl)-1-propanamine; 3-(3,4-dimethylphenyl)propylamine
|
|
C11H17N |
详情 |
详情
|
(VIII) |
40289 |
4-Hydroxy-3-methoxyphenylacetic acid; Homovanillic acid; 2-(4-hydroxy-3-methoxyphenyl)acetic acid
|
306-08-1 |
C9H10O4 |
详情 | 详情
|
(IX) |
40290 |
N-[3-(3,4-dimethylphenyl)propyl]-2-(4-hydroxy-3-methoxyphenyl)acetamide
|
|
C20H25NO3 |
详情 |
详情
|
(X) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XI) |
40291 |
2-[4-(2-bromoethoxy)-3-methoxyphenyl]-N-[3-(3,4-dimethylphenyl)propyl]acetamide
|
|
C22H28BrNO3 |
详情 |
详情
|
(XII) |
40292 |
2-[4-(2-azidoethoxy)-3-methoxyphenyl]-N-[3-(3,4-dimethylphenyl)propyl]acetamide
|
|
C22H28N4O3 |
详情 |
详情
|
合成路线35
该中间体在本合成路线中的序号:
(XVII) In a different protection strategy, (diethoxyethyl)malonate (XIX) was obtained by alkylation of diethyl malonate (XVII) with bromoacetaldehyde diethyl acetal (XVIII). Reduction of the ester groups of (XIX) with LiBH4 provided diol (XX). The asymmetric mono-acetate ester (XXI) was generated by enantioselective acylation of the prochiral diol (XX) with vinyl acetate in the presence of lipase PS 30. Reaction of the free hydroxyl of (XXI) with p-toluenesulfonyl chloride afforded tosylate (XXII), which was subsequently condensed with 2-amino-6-chloropurine (I), yielding adduct (XXIII). Conversion of the chloropurine ring of (XXIII) to the target guanine derivative (XXV) was achieved by displacement of the chloro group with benzyl alcohol, with concomitant acetate ester hydrolysis, followed by hydrogenolytic cleavage of the resultant benzyl ether (XXIV). Alternatively, initial acetate ester hydrolysis in (XXIII) gave alcohol (XXVI), which was further subjected to chloro group hydrolysis in the presence of either KOH or tertiary amines to yield (XXV). Conversion of alcohol (XXV) to the target stearate ester (XXVIII) was achieved by treatment with stearoyl chloride (IX) or with the mixed anhydride of stearic acid (XXVII) with pivaloyl chloride or with tosyl chloride.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11644 |
6-Chloro-9H-purin-2-amine; 6-Chloro-9H-purin-2-ylamine; 2-Amino-6-chloropurine
|
10310-21-1 |
C5H4ClN5 |
详情 | 详情
|
(IX) |
52961 |
n-Octadecanoyl chloride; Octadecanoyl Chloride; Stearic acid chloride; Stearoyl chloride
|
112-76-5 |
C18H35ClO |
详情 | 详情
|
(XVII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XVIII) |
12113 |
2-Bromo-1-ethoxyethyl ethyl ether; 2-Bromo-1,1-diethoxyethane; Bromoacetaldehyde diethylacetal
|
2032-35-1 |
C6H13BrO2 |
详情 | 详情
|
(XIX) |
52968 |
3,3-Diethoxypropane-1,1-dicarboxylic acid diethyl ester; Diethyl 3,3-Diethoxypropane-1,1-dicarboxylate
|
21339-47-9 |
C13H24O6 |
详情 | 详情
|
(XX) |
52969 |
2-(2,2-Diethoxyethyl)-1,3-propanediol; 2-Hydroxymethyl-4,4-diethoxybutanol
|
55387-85-4 |
C9H20O4 |
详情 | 详情
|
(XXI) |
52970 |
(2R)-4,4-diethoxy-2-(hydroxymethyl)butyl acetate
|
|
C11H22O5 |
详情 |
详情
|
(XXII) |
52971 |
(2S)-4,4-diethoxy-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)butyl acetate
|
|
C18H28O7S |
详情 |
详情
|
(XXIII) |
52972 |
(2R)-2-[(2-amino-6-chloro-9H-purin-9-yl)methyl]-4,4-diethoxybutyl acetate
|
|
C16H24ClN5O4 |
详情 |
详情
|
(XXIV) |
52973 |
(2R)-2-{[2-amino-6-(benzyloxy)-9H-purin-9-yl]methyl}-4,4-diethoxy-1-butanol
|
|
C21H29N5O4 |
详情 |
详情
|
(XXV) |
52974 |
2-amino-9-[(2R)-4,4-diethoxy-2-(hydroxymethyl)butyl]-1,9-dihydro-6H-purin-6-one
|
|
C14H23N5O4 |
详情 |
详情
|
(XXVI) |
52975 |
(2R)-2-[(2-amino-6-chloro-9H-purin-9-yl)methyl]-4,4-diethoxy-1-butanol
|
|
C14H22ClN5O3 |
详情 |
详情
|
(XXVII) |
27095 |
stearic acid
|
57-11-4 |
C18H36O2 |
详情 | 详情
|
(XXVIII) |
52976 |
(2R)-2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]-4,4-diethoxybutyl stearate
|
|
C32H57N5O5 |
详情 |
详情
|
合成路线36
该中间体在本合成路线中的序号:
(X) The sulfonation of 4-chlorodiphenyl ether (I) with chlorosulfonic acid in dichloromethane gives the 4-(4-chlorophenoxy)benzenesulfonic acid (II), which is treated with oxalyl chloride and DMF in the same solvent yielding the sulfonyl chloride (III). The reduction of (III) with trimethyl phosphite and KOH in toluene affords the methylsulfanyl derivative (IV), which is chlorinated with SO2Cl2 in dichloromethane to give the chloromethylsulfanyl derivative (V). The condensation of (V) with the silylated enol ether (VI) by means of ZnCl2 and KOH in refluxing dichloromethane yields 4-[4-(4-chlorophenoxy)phenylsulfanylmethyl]tetrahydropyran-4-carboxylic acid (VII), which is treated with oxalyl chloride affording the corresponding acyl chloride (VIII). The reaction of (VIII) with NH2OH in dichloromethane provides the carbohydroxamic acid (IX), which is finally oxidized with oxone (potassium peroxymonosulfate) in N-methyl-2-pyrrolidone/H2O to furnish the target sulfone.
【1】
Zook, S.E.; Dagnino, R. Jr.; Deason, M.E.; Bender, S.L.; Melnick, M.J. (Agouron Pharmaceuticals, Inc.); Metalloproteinase inhibitors, pharmaceutical compsns. containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation. EP 0874830; JP 2000502330; WO 9720824 . |
【2】
Campbell, J.A.; Dvorak, C.A.; Fisher, L.E.; McGrane, P.L. (F. Hoffmann-La Roche AG); Process for preparing 3-arylsulfur hydroxamic acids. EP 0965592 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
39894 |
1-chloro-4-phenoxybenzene; 4-chlorophenyl phenyl ether
|
7005-72-3 |
C12H9ClO |
详情 | 详情
|
(II) |
39895 |
4-(4-chlorophenoxy)benzenesulfonic acid
|
|
C12H9ClO4S |
详情 |
详情
|
(III) |
39896 |
4-(4-chlorophenoxy)benzenesulfonyl chloride
|
|
C12H8Cl2O3S |
详情 |
详情
|
(IV) |
39897 |
4-chlorophenyl 4-(methylsulfanyl)phenyl ether; 1-(4-chlorophenoxy)-4-(methylsulfanyl)benzene
|
225652-11-9 |
C13H11ClOS |
详情 | 详情
|
(V) |
39898 |
1-[(chloromethyl)sulfanyl]-4-(4-chlorophenoxy)benzene; 4-[(chloromethyl)sulfanyl]phenyl 4-chlorophenyl ether
|
|
C13H10Cl2OS |
详情 |
详情
|
(VI) |
39899 |
ethoxy(tetrahydro-4H-pyran-4-ylidene)methyl trimethylsilyl ether; [ethoxy(tetrahydro-4H-pyran-4-ylidene)methoxy](trimethyl)silane
|
|
C11H22O3Si |
详情 |
详情
|
(VII) |
39900 |
4-([[4-(4-chlorophenoxy)phenyl]sulfanyl]methyl)tetrahydro-2H-pyran-4-carboxylic acid
|
|
C19H19ClO4S |
详情 |
详情
|
(VIII) |
39901 |
4-([[4-(4-chlorophenoxy)phenyl]sulfanyl]methyl)tetrahydro-2H-pyran-4-carbonyl chloride
|
|
C19H18Cl2O3S |
详情 |
详情
|
(IX) |
39902 |
4-([[4-(4-chlorophenoxy)phenyl]sulfanyl]methyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide
|
|
C19H20ClNO4S |
详情 |
详情
|
(X) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XI) |
12060 |
Bis(2-chloroethyl) ether; 1-Chloro-2-(2-chloroethoxy)ethane; 2,2'-Dichlorodiethyl ether
|
111-44-4 |
C4H8Cl2O |
详情 | 详情
|
(XII) |
18726 |
diethyl tetrahydro-4H-pyran-4,4-dicarboxylate
|
|
C11H18O5 |
详情 |
详情
|
(XIII) |
39003 |
N-butyl-2-cyclohexylacetamide
|
|
C12H23NO |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(I) Alkylation of diethyl malonate (I) with chloroethyl ether (II) in the presence of NaOEt in refluxing EtOH provided tetrahydropyran dicarboxylate (III). Hydrolysis of diester (III) with ethanolic KOH, and decarboxylation of the resulting diacid (IV) at 180 C gave tetrahydropyran-4-carboxylic acid (V). This was reduced to the alcohol (VI) on treatment with LiAlH4 in refluxing THF, and then converted into mesylate (VII) by reaction with metanesulfonyl chloride and triethylamine in THF. 3-(Aminomethyl)pyridine (VIII) was protected as the imine (X) by reaction with benzophenone (IX) in refluxing benzene with a Dean-Stark trap. Alkylation of imine (X) with mesylate (VII) in the presence of LDA in cold THF gave intermediate (XI) which, on acidic hydrolysis provided amine (XII). Reaction of (XII) with saturated aqueous HBr at 100 C in a pressure tube formed dibromide (XIII), which was basified with K2CO3 and heated to 80 C to provide the target quinuclidine.
【1】
Bencherif, M.; Lippiello, P.M.; Caldwell, W.S. (R.J. Reynolds Tobacco Co.); Depolarizing skeletal muscle relaxants. WO 9607410 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
12060 |
Bis(2-chloroethyl) ether; 1-Chloro-2-(2-chloroethoxy)ethane; 2,2'-Dichlorodiethyl ether
|
111-44-4 |
C4H8Cl2O |
详情 | 详情
|
(III) |
18726 |
diethyl tetrahydro-4H-pyran-4,4-dicarboxylate
|
|
C11H18O5 |
详情 |
详情
|
(IV) |
18727 |
tetrahydro-4H-pyran-4,4-dicarboxylic acid
|
|
C7H10O5 |
详情 |
详情
|
(V) |
18728 |
tetrahydro-2H-pyran-4-carboxylic acid
|
|
C6H10O3 |
详情 |
详情
|
(VI) |
18729 |
tetrahydro-2H-pyran-4-ylmethanol
|
|
C6H12O2 |
详情 |
详情
|
(VII) |
18730 |
tetrahydro-2H-pyran-4-ylmethyl methanesulfonate
|
|
C7H14O4S |
详情 |
详情
|
(VIII) |
18731 |
3-pyridinylmethanamine; 3-pyridinylmethylamine
|
3731-52-0 |
C6H8N2 |
详情 | 详情
|
(IX) |
18732 |
benzophenone
|
119-61-9 |
C13H10O |
详情 | 详情
|
(X) |
18733 |
N-(dibenzylene)(3-pyridinyl)methanamine; N-(dibenzylene)-N-(3-pyridinylmethyl)amine
|
|
C19H16N2 |
详情 |
详情
|
(XI) |
18734 |
N-(dibenzylene)-N-[1-(3-pyridinyl)-2-tetrahydro-2H-pyran-4-ylethyl]amine; N-(dibenzylene)-1-(3-pyridinyl)-2-tetrahydro-2H-pyran-4-yl-1-ethanamine
|
|
C25H26N2O |
详情 |
详情
|
(XII) |
18735 |
1-(3-pyridinyl)-2-tetrahydro-2H-pyran-4-ylethylamine; 1-(3-pyridinyl)-2-tetrahydro-2H-pyran-4-yl-1-ethanamine
|
|
C12H18N2O |
详情 |
详情
|
(XIII) |
18736 |
5-bromo-3-(2-bromoethyl)-1-(3-pyridinyl)-1-pentanamine; 5-bromo-3-(2-bromoethyl)-1-(3-pyridinyl)pentylamine
|
|
C12H18Br2N2 |
详情 |
详情
|
合成路线38
该中间体在本合成路线中的序号:
(IV) The reduction of diethyl 2-phenylmalonate (I) with LiAlH4 in ethyl ether gives the expected diol (II), which is tosylated with tosyl chloride and pyridine yielding the ditosylate (III). The cyclization of (III) with diethyl malonate (IV) by means of NaH in dioxane affords the diethyl 3-phenylcyclobutane-1,1-dicarboxylate (V), which is saponified with KOH to the diacid (VI). The partial decarboxylation of (VI) by heating at 200 C provides 3-phenylcyclobutane-1-carboxylic acid (VII), which is esterified with phenacyl bromide to the corresponding phenacyl ester (VIII). The oxidation of (VIII) with ruthenium chloride and periodic acid gives cyclobutane-1,3-dicarboxylic acid monophenacyl ester (IX) as a 1:1 mixture of the cis and trans isomers. The condensation of (IX) with malonic acid monoethyl ester (X) by means of oxalyl chloride and BuLi in THF yields tyhe intermediate diester (XI), which is condensed with thioxanthen (XII) in acetic acid to provide the thioxanthenyl acetic ester (XIII). The decarboxylative hydrolysis of (XIII) with NaOH in ethanol gives the ketoacid (XIV), which is cyclized with KCN and ammonium carbonate in ethanol/water yielding the imidazolidinedione (XV). The hydrolysis of (XV) with NaOH affords the 3-[1-amino-1-carboxy-2-(9-thioxanthenyl)ethyl]cyclobutane-1-carboxylic acid (XVI) as a 2:1 mixture of the cis and trans racemates. Finally, this mixture is treated with L-lysine and crystallized to afford the pure target compound.
【1】
Clark, B.P.; et al.; alpha-Substituted-cyclobutylglycine LY393675 potently antagonises group 1 metabotropic glutamate receptors. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.125. |
【2】
Clark, B.P.; Harris, J.R. (Eli Lilly and Company); Pharmaceutical acidic cpds.. EP 0837061; JP 1998120635; US 6054448 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10315 |
2-Bromo-1-phenyl-ethanone; 2-Bromo-1-phenyl-1-ethanone
|
70-11-1 |
C8H7BrO |
详情 | 详情
|
(I) |
26952 |
diethyl 2-phenylmalonate
|
83-13-6 |
C13H16O4 |
详情 | 详情
|
(II) |
24198 |
2-phenyl-1,3-propanediol
|
|
C9H12O2 |
详情 |
详情
|
(III) |
26953 |
3-[[(4-methylphenyl)sulfonyl]oxy]-2-phenylpropyl 4-methylbenzenesulfonate
|
|
C23H24O6S2 |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
26954 |
diethyl 3-phenyl-1,1-cyclobutanedicarboxylate
|
|
C16H20O4 |
详情 |
详情
|
(VI) |
26955 |
3-phenyl-1,1-cyclobutanedicarboxylic acid
|
|
C12H12O4 |
详情 |
详情
|
(VII) |
26956 |
3-phenylcyclobutanecarboxylic acid
|
|
C11H12O2 |
详情 |
详情
|
(VIII) |
26957 |
2-oxo-2-phenylethyl 3-phenylcyclobutanecarboxylate
|
|
C19H18O3 |
详情 |
详情
|
(IX) |
26958 |
3-[(2-oxo-2-phenylethoxy)carbonyl]cyclobutanecarboxylic acid
|
|
C14H14O5 |
详情 |
详情
|
(X) |
15086 |
3-ethoxy-3-oxopropionic acid
|
1071-46-1 |
C5H8O4 |
详情 | 详情
|
(XI) |
26959 |
2-oxo-2-phenylethyl 3-(3-ethoxy-3-oxopropanoyl)cyclobutanecarboxylate
|
|
C18H20O6 |
详情 |
详情
|
(XII) |
26071 |
9H-thioxanthen-9-ol
|
|
C13H10OS |
详情 |
详情
|
(XIII) |
26960 |
2-oxo-2-phenylethyl 3-[3-ethoxy-3-oxo-2-(9H-thioxanthen-9-yl)propanoyl]cyclobutanecarboxylate
|
|
C31H28O6S |
详情 |
详情
|
(XIV) |
26961 |
3-[2-(9H-thioxanthen-9-yl)acetyl]cyclobutanecarboxylic acid
|
|
C20H18O3S |
详情 |
详情
|
(XV) |
26962 |
3-[2,5-dioxo-4-(9H-thioxanthen-9-ylmethyl)-4-imidazolidinyl]cyclobutanecarboxylic acid
|
|
C22H20N2O4S |
详情 |
详情
|
(XVI) |
26963 |
3-[1-amino-1-carboxy-2-(9H-thioxanthen-9-yl)ethyl]cyclobutanecarboxylic acid
|
|
C21H21NO4S |
详情 |
详情
|
合成路线39
该中间体在本合成路线中的序号:
(I) The reaction of monolabeled diethyl malonate (I) with 2-benzyloxyethyl bromide (II) by means of NaH in refluxing THF gives the corresponding benzyloxyethyl derivative (III), which is reduced with LiAlH4 in ethyl ether yielding the diol (IV). The protection of (IV) by reaction with 2,2-dimethoxypropane (V) and p-toluenesulfonic acid affords the 1,3-dioxane (VI), which is debenzylated with H2 over Pd/C in THF giving the alcohol (VII). The reaction of (VII) with CBr4 and PPh3 in DMF yields the bromide (VIII), which is condensed with the purine (IX) by means of K2CO3 in DMF affording the expected purin-9-yl derivative (X). The hydrolysis of the 1,3-dioxane group with AcOH /water gives the diol (XI), which is monoacylated with isopropyl chloroformate (XII) by means of cool pyridine yielding the mixture of regioisomers (XIII), (XIV). Finally, this mixture is dechlorinated with ammonium formate over Pd/C in refluxing methanol afffording the target compound also as a mixture of regioisomers.
【1】
Kim, D.K.; et al.; Synthesis of carbon-14 labelled 2-amino-9-(3-hydroxymethyl-4-isopropoxycarbonyloxybut-1-yl)purine (SK 1875), a potential prodrug of penciclovir. J Label Compd Radiopharm 1999, 42, 6, 597.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII),(VIII) |
10916 |
2-(2,2-Dimethyl-1,3-dioxan-5-yl)-1-ethanol
|
|
C8H16O3 |
详情 |
详情
|
(XIII),(XIV) |
35533 |
4-(2-amino-6-chloro-9H-purin-9-yl)-2-(hydroxymethyl)butyl isopropyl carbonate
|
|
C14H20ClN5O4 |
详情 |
详情
|
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(I) |
45348 |
diethyl malonate
|
|
C7H12O4 |
详情 |
详情
|
(II) |
35528 |
1-[(2-bromoethoxy)methyl]benzene; benzyl 2-bromoethyl ether
|
1462-37-9 |
C9H11BrO |
详情 | 详情
|
(III) |
35529 |
diethyl 2-[2-(benzyloxy)ethyl]malonate
|
|
C16H22O5 |
详情 |
详情
|
(III) |
45349 |
diethyl 2-[2-(benzyloxy)ethyl]malonate
|
|
C16H22O5 |
详情 |
详情
|
(IV) |
35523 |
2-[2-(benzyloxy)ethyl]-1,3-propanediol
|
|
C12H18O3 |
详情 |
详情
|
(IV) |
45350 |
2-[2-(benzyloxy)ethyl]-1,3-propanediol
|
|
C12H18O3 |
详情 |
详情
|
(V) |
10722 |
1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane
|
77-76-9 |
C5H12O2 |
详情 | 详情
|
(VI) |
35530 |
5-[2-(benzyloxy)ethyl]-2,2-dimethyl-1,3-dioxane; benzyl 2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl ether
|
|
C15H22O3 |
详情 |
详情
|
(VI) |
45351 |
5-[2-(benzyloxy)ethyl]-2,2-dimethyl-1,3-dioxane; benzyl 2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl ether
|
|
C15H22O3 |
详情 |
详情
|
(VII) |
45352 |
2-(2,2-dimethyl-1,3-dioxan-5-yl)-1-ethanol
|
|
C8H16O3 |
详情 |
详情
|
(VIII) |
45353 |
2-(2,2-dimethyl-1,3-dioxan-5-yl)-1-ethanol
|
|
C8H16O3 |
详情 |
详情
|
(IX) |
11644 |
6-Chloro-9H-purin-2-amine; 6-Chloro-9H-purin-2-ylamine; 2-Amino-6-chloropurine
|
10310-21-1 |
C5H4ClN5 |
详情 | 详情
|
(X) |
35531 |
6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-ylamine; 6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amine
|
|
C13H18ClN5O2 |
详情 |
详情
|
(X) |
45354 |
6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amine; 6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-ylamine
|
|
C13H18ClN5O2 |
详情 |
详情
|
(XI) |
35532 |
2-[2-(2-amino-6-chloro-9H-purin-9-yl)ethyl]-1,3-propanediol
|
|
C10H14ClN5O2 |
详情 |
详情
|
(XI) |
45355 |
2-[2-(2-amino-6-chloro-9H-purin-9-yl)ethyl]-1,3-propanediol
|
|
C10H14ClN5O2 |
详情 |
详情
|
(XII) |
26492 |
2-[(chlorocarbonyl)oxy]propane
|
108-23-6 |
C4H7ClO2 |
详情 | 详情
|
(XIII) |
45356 |
4-(2-amino-6-chloro-9H-purin-9-yl)-2-(hydroxymethyl)butyl isopropyl carbonate
|
|
C14H20ClN5O4 |
详情 |
详情
|
(XIV) |
45357 |
4-(2-amino-6-chloro-9H-purin-9-yl)-2-(hydroxymethyl)butyl isopropyl carbonate
|
|
C14H20ClN5O4 |
详情 |
详情
|
合成路线40
该中间体在本合成路线中的序号:
(XII) The reaction of 3-chlorotetrafluoropyridine (I) with sodium tert-butoxide in THF gives 4-(tert-butoxy)-3-chloro-2,5,6-trifluoropyridine (II), which is dechlorinated with H2 over Pearlman's catalyst in methanol yielding 4-(tert-butoxy)-2,3,6-trifluoropyridine (III). The methylation of (III) with methyl iodide and lithium diethylamide (LDA) in THF affords 4-(tert-butoxy)-2,3,6-trifluoro-5-methylpyridine (IV), which is treated with hydrazine in refluxing propanol to give 4-(tert-butoxy)-2,5-difluoro-3-methylpyridine (V). The condensation of (V) with 2-bromo-2-cyclopropylacetopnitrile (VI) by means of LDA in THF yields the expected condensation product (VII), which is treated with TFA to eliminate the tert-butyl protecting group and with POCl3 in DMF to afford the 4-chloropyridyl derivative (VIII). The hydrolysis of the nitrile group of (VIII) with HCl in ethanol gives the corresponding acetate ester (IX), which is reduced with LiAlH4 in THF to the alcohol (X). The oxidation of (X) with oxalyl chloride in DMSO/dichloromethane yields the aldehyde (XI), which is cyclized with diethyl malonate (XII) by means of piperidine in refluxing acetic acid, followed by heating at 220 C C in Dowtherm to afford 8-chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester (XIII). The condensation of (XIII) with 7(S)-(tert-butoxycarbonylamino)-5-azaspiro[2.4]heptane (XIV) by means of triethylamine in DMF gives the expected condensation product (XV), which is methylated with methyl iodide and sodium hexamethyldisylazane (Na-HMDS) in THF yielding the N-methyl derivative (XVI). The hydrolysis of the ester group of (XVI) with LiOH in THF/water provides the corresponding free acid (XVII), which is finally deprotected with HCl in acetic acid.
The synthesis of the intermediate 7(S)-(tert-butoxycarbonylamino)-5-azaspiro[2.4]heptane (XIV) has already been described in the first synthesis of compound no. 268134 (see scheme 26813401a).
【1】
Or, Y.S.; Armiger, Y.-L.; Fung, A. (Abbott Laboratories Inc.); Pyridone antibiotic with improved safety profile. US 5977133; WO 0010998 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16189 |
(2R)-2-(1-benzothiophen-5-yl)-2-hydroxyethanoic acid
|
|
C10H8O3S |
详情 |
详情
|
(II) |
16820 |
4-(tert-butoxy)-3-chloro-2,5,6-trifluoropyridine; tert-butyl 3-chloro-2,5,6-trifluoro-4-pyridinyl ether
|
|
C9H9ClF3NO |
详情 |
详情
|
(III) |
16821 |
4-(tert-butoxy)-2,3,6-trifluoropyridine; tert-butyl 2,3,6-trifluoro-4-pyridinyl ether
|
|
C9H10F3NO |
详情 |
详情
|
(IV) |
16822 |
tert-butyl 2,3,6-trifluoro-5-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,3,6-trifluoro-5-methylpyridine
|
|
C10H12F3NO |
详情 |
详情
|
(V) |
16823 |
tert-butyl 2,5-difluoro-3-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,5-difluoro-3-methylpyridine
|
|
C10H13F2NO |
详情 |
详情
|
(VI) |
31629 |
2-bromo-2-cyclopropylacetonitrile
|
|
C5H6BrN |
详情 |
详情
|
(VII) |
16825 |
2-[4-(tert-butoxy)-5-fluoro-3-methyl-2-pyridinyl]-2-cyclopropylacetonitrile
|
|
C15H19FN2O |
详情 |
详情
|
(VIII) |
16826 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetonitrile
|
|
C11H10ClFN2 |
详情 |
详情
|
(IX) |
16827 |
ethyl 2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetate
|
|
C13H15ClFNO2 |
详情 |
详情
|
(X) |
31627 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropyl-1-ethanol
|
|
C11H13ClFNO |
详情 |
详情
|
(XI) |
16828 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetaldehyde
|
|
C11H11ClFNO |
详情 |
详情
|
(XII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XIII) |
16831 |
ethyl 8-chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C16H15ClFNO3 |
详情 |
详情
|
(XIV) |
15193 |
tert-butyl N-[(7S)-5-azaspiro[2.4]hept-7-yl]carbamate
|
|
C11H20N2O2 |
详情 |
详情
|
(XV) |
26950 |
ethyl 8-[(7S)-7-[(tert-butoxycarbonyl)amino]-5-azaspiro[2.4]hept-5-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C27H34FN3O5 |
详情 |
详情
|
(XVI) |
16951 |
(1R)-1-[(4S,5R)-2,2-dimethyl-5-[(E)-1-tetradecenyl]-1,3-dioxolan-4-yl]-2-(trityloxy)-1-ethanol
|
|
C40H54O4 |
详情 |
详情
|
(XVII) |
31628 |
8-[(7S)-7-[(tert-butoxycarbonyl)(methyl)amino]-5-azaspiro[2.4]hept-5-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid
|
|
C26H32FN3O5 |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(XII) The reaction of 3-chlorotetrafluoropyridine (I) with potassium tert-butoxide in THF gives the 4-tert-butoxypyridine (II), which is dechlorinated with H2 over Pearlman's catalyst in methanol yielding 4-tert-butoxy-2,3,6-trifluoropyridine (III). The methylation of (III) with methyl iodide and LDA in THF affords the 5-methyl derivative (IV), which is partially defluorinated with hydrazine in refluxing propanol to provide 4-tert-butoxy-2,5-difluoro-3-methylpyridine (V). The condensation of (V) with cyclopropylacetonitrile (VI) by means of LDA in THF gives the alpha substituted acetonitrile (VII), which is treated with trifluoroacetic acid yielding the phenol (VIII). The reaction of (VIII) with POCl3 in dichloromethane/DMF affords the corresponding chloro derivative (IX), which is treated with dry HCl in ethanol giving the carboxylic ester (X). The reduction of (X) with LiAlH4 in THF affords the expected aldehyde (XI), which is cyclized with diethyl malonate, piperidine and acetic acid in refluxing ethanol giving the quinolizine carboxylate (XIII). The reaction of (XIII) with (1S,6S)-2-(tert-butoxycarbonyl)-2,8-diazabicyclo[4.3.0]nonane (XIV) by means of NaHCO3 in refluxing acetonitrile yields the condensation product (XV), which is saponified with LiOH in THF/wter providing the protcted target compound (XVI). Finally, this compound is deprotected with HCl in dioxane/methylene chloride.
【1】
Chu, D.T.; Li, Q.; Cooper, C.S.; Fung, A.K.L.; Lee, C.M.; Plattner, J.J.; Ma, Z.; Wang, W.-B. (Abbott Laboratories Inc.); Quinolizinone type cpds.. EP 0871628; JP 1999510478; WO 9639407 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16819 |
3-chloro-2,4,5,6-tetrafluoropyridine; Pyridine, 3-chloro-2,4,5,6-tetrafluoro-
|
1735-84-8 |
C5ClF4N |
详情 | 详情
|
(II) |
16820 |
4-(tert-butoxy)-3-chloro-2,5,6-trifluoropyridine; tert-butyl 3-chloro-2,5,6-trifluoro-4-pyridinyl ether
|
|
C9H9ClF3NO |
详情 |
详情
|
(III) |
16821 |
4-(tert-butoxy)-2,3,6-trifluoropyridine; tert-butyl 2,3,6-trifluoro-4-pyridinyl ether
|
|
C9H10F3NO |
详情 |
详情
|
(IV) |
16822 |
tert-butyl 2,3,6-trifluoro-5-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,3,6-trifluoro-5-methylpyridine
|
|
C10H12F3NO |
详情 |
详情
|
(V) |
16823 |
tert-butyl 2,5-difluoro-3-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,5-difluoro-3-methylpyridine
|
|
C10H13F2NO |
详情 |
详情
|
(VI) |
16824 |
2-cyclopropylacetonitrile; Cyclopropylacetonitrile
|
6542-60-5 |
C5H7N |
详情 | 详情
|
(VII) |
16825 |
2-[4-(tert-butoxy)-5-fluoro-3-methyl-2-pyridinyl]-2-cyclopropylacetonitrile
|
|
C15H19FN2O |
详情 |
详情
|
(VIII) |
27200 |
2-cyclopropyl-2-(5-fluoro-4-hydroxy-3-methyl-2-pyridinyl)acetonitrile
|
|
C11H11FN2O |
详情 |
详情
|
(IX) |
16826 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetonitrile
|
|
C11H10ClFN2 |
详情 |
详情
|
(X) |
16827 |
ethyl 2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetate
|
|
C13H15ClFNO2 |
详情 |
详情
|
(XI) |
16828 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetaldehyde
|
|
C11H11ClFNO |
详情 |
详情
|
(XII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XIII) |
16831 |
ethyl 8-chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C16H15ClFNO3 |
详情 |
详情
|
(XIV) |
27201 |
tert-butyl (4aS,7aS)octahydro-1H-pyrrolo[3,4-b]pyridine-1-carboxylate
|
|
C12H22N2O2 |
详情 |
详情
|
(XV) |
27202 |
ethyl 8-[(4aS,7aS)-1-(tert-butoxycarbonyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C28H36FN3O5 |
详情 |
详情
|
(XVI) |
27203 |
8-[(4aS,7aS)-1-(tert-butoxycarbonyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid
|
|
C26H32FN3O5 |
详情 |
详情
|
合成路线42
该中间体在本合成路线中的序号:
(IV) Isobutyraldehyde (I) was condensed with vinylmagnesium bromide (II) to provide allylic alcohol (III). Condensation of (III) with diethyl malonate (IV) in the presence of titanium ethoxide, followed by Claisen rearrangement at 190 C gave malonate (V). Subsequent basic hydrolysis of (V) with concomitant decarboxylation yielded 6-methyl-4-heptenoic acid (VI). This was transformed to the corresponding acid chloride by means of SOCl2 and then coupled with (1R,2R)-(-)-pseudoephedrine (VII) to produce the chiral amide (VIII). Alkylation of the dianion of (VIII) with benzyl bromide (IX) in the presence of LiCl afforded the benzylated compound (X). Further treatment of (X) with N-bromosuccinimide and AcOH in THF generated the bromolactone (XI). The bromo group of (XI) was then displaced with NaN3, and the resulting azide (XII) was hydrogenated in the presence of di-tert-butyl dicarbonate to provide carbamate (XIII). Basic hydrolysis of the lactone (XII) gave hydroxyacid (XIV), which was oxidized to ketoacid (XV) by means of N-methylmorpholine-N-oxide and tetrapropyl ammonium perruthenate.
【1】
Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(II) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(III) |
24605 |
4-methyl-1-penten-3-ol
|
|
C6H12O |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
24607 |
diethyl 2-[(E)-4-methyl-2-pentenyl]malonate
|
|
C13H22O4 |
详情 |
详情
|
(VI) |
24608 |
(E)-6-methyl-4-heptenoic acid
|
|
C8H14O2 |
详情 |
详情
|
(VII) |
24609 |
(1R,2R)-2-(methylamino)-1-phenyl-1-propanol
|
|
C10H15NO |
详情 |
详情
|
(VIII) |
24610 |
(E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide
|
|
C18H27NO2 |
详情 |
详情
|
(IX) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(X) |
24634 |
(2S,4E)-2-benzyl-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide
|
|
C25H33NO2 |
详情 |
详情
|
(XI) |
24635 |
(3R,5S)-3-benzyl-5-[(1R)-1-bromo-2-methylpropyl]dihydro-2(3H)-furanone
|
|
C15H19BrO2 |
详情 |
详情
|
(XII) |
24636 |
(3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-benzyldihydro-2(3H)-furanone
|
|
C15H19N3O2 |
详情 |
详情
|
(XIII) |
24637 |
tert-butyl (1S)-1-[(2S,4R)-4-benzyl-5-oxotetrahydro-2-furanyl]-2-methylpropylcarbamate
|
|
C20H29NO4 |
详情 |
详情
|
(XIV) |
24638 |
(2R,4S,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-6-methylheptanoic acid
|
|
C20H31NO5 |
详情 |
详情
|
(XV) |
24639 |
(2R,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-6-methyl-4-oxoheptanoic acid
|
|
C20H29NO5 |
详情 |
详情
|
合成路线43
该中间体在本合成路线中的序号:
(IV) Isobutyraldehyde (I) was condensed with vinylmagnesium bromide (II) to provide allylic alcohol (III).Transesterification with diethyl malonate (IV) in the presence of titanium ethoxide, followed by Claisen rearrangement at 190 C gave malonate (V). Subsequent basic hydrolysis of (V) with concomitant decarboxylation yielded 6-methyl-4-heptenoic acid (VI). This was transformed to the corresponding acid chloride by means of SOCl2 and then coupled with (1R,2R)-(-)-pseudoephedrine (VII) to produce the chiral amide (VIII). Alkylation of the dianion of (VIII) with 4-methylbenzyl bromide (IX) in the presence of LiCl afforded the benzylated compound (X). Further treatment of (X) with N-bromosuccinimide and AcOH in THF generated the bromolactone (XI). The bromo group of (XI) was then displaced with NaN3, and the resulting azide (XII) was hydrogenated in the presence of di-tert-butyl dicarbonate to provide carbamate (XIII). Basic hydrolysis of the lactone (XIII) gave hydroxyacid (XIV), which was oxidized to ketoacid (XV) by means of N-methylmorpholine-N-oxide and tetrapropyl ammonium perruthenate.
【1】
Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(II) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(III) |
24605 |
4-methyl-1-penten-3-ol
|
|
C6H12O |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(VI) |
24608 |
(E)-6-methyl-4-heptenoic acid
|
|
C8H14O2 |
详情 |
详情
|
(VII) |
24609 |
(1R,2R)-2-(methylamino)-1-phenyl-1-propanol
|
|
C10H15NO |
详情 |
详情
|
(VIII) |
24610 |
(E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide
|
|
C18H27NO2 |
详情 |
详情
|
(IX) |
24623 |
1-(bromomethyl)-4-methylbenzene
|
104-81-4 |
C8H9Br |
详情 | 详情
|
(X) |
24624 |
(2S,4E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-2-(4-methylbenzyl)-4-heptenamide
|
|
C26H35NO2 |
详情 |
详情
|
(XI) |
24625 |
(3R,5S)-5-[(1R)-1-bromo-2-methylpropyl]-3-(4-methylbenzyl)dihydro-2(3H)-furanone
|
|
C16H21BrO2 |
详情 |
详情
|
(XII) |
24626 |
(3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-(4-methylbenzyl)dihydro-2(3H)-furanone
|
|
C16H21N3O2 |
详情 |
详情
|
(XIII) |
24627 |
tert-butyl (1S)-2-methyl-1-[(2S,4R)-4-(4-methylbenzyl)-5-oxotetrahydro-2-furanyl]propylcarbamate
|
|
C21H31NO4 |
详情 |
详情
|
(XIV) |
24628 |
(2R,4S,5S)-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-6-methyl-2-(4-methylbenzyl)heptanoic acid
|
|
C21H33NO5 |
详情 |
详情
|
(XV) |
24629 |
(2R,5S)-5-[(tert-butoxycarbonyl)amino]-6-methyl-2-(4-methylbenzyl)-4-oxoheptanoic acid
|
|
C21H31NO5 |
详情 |
详情
|
合成路线44
该中间体在本合成路线中的序号:
(IV) Isobutyraldehyde (I) was condensed with vinylmagnesium bromide (II) to provide allylic alcohol (III).Transesterification with diethyl malonate (IV) in the presence of titanium ethoxide, followed by Claisen rearrangement at 190 C gave malonate (V). Subsequent basic hydrolysis of (V) with concomitant decarboxylation yielded 6-methyl-4-heptenoic acid (VI). This was transformed to the corresponding acid chloride by means of SOCl2 and then coupled with (1R,2R)-(-)-pseudoephedrine (VII) to produce the chiral amide (VIII). Alkylation of the dianion of (VIII) with 4-flourobenzyl bromide (IX) in the presence of LiCl afforded the benzylated compound (X). Further treatment of (X) with N-bromosuccinimide and AcOH in THF generated the bromolactone (XI). The bromo group of (XI) was then displaced with NaN3, and the resulting azide (XII) was hydrogenated in the presence of di-tert-butyl dicarbonate to provide carbamate (XIII). Basic hydrolysis of the lactone (XIII) gave hydroxyacid (XIV), which was oxidized to ketoacid (XV) by means of N-methylmorpholine-N-oxide and tetrapropyl ammonium perruthenate.
【1】
Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(II) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(III) |
24605 |
4-methyl-1-penten-3-ol
|
|
C6H12O |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
24607 |
diethyl 2-[(E)-4-methyl-2-pentenyl]malonate
|
|
C13H22O4 |
详情 |
详情
|
(VI) |
24608 |
(E)-6-methyl-4-heptenoic acid
|
|
C8H14O2 |
详情 |
详情
|
(VII) |
24609 |
(1R,2R)-2-(methylamino)-1-phenyl-1-propanol
|
|
C10H15NO |
详情 |
详情
|
(VIII) |
24610 |
(E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide
|
|
C18H27NO2 |
详情 |
详情
|
(IX) |
24611 |
1-(bromomethyl)-4-fluorobenzene
|
459-46-1 |
C7H6BrF |
详情 | 详情
|
(X) |
24612 |
(2S,4E)-2-(4-fluorobenzyl)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,6-dimethyl-4-heptenamide
|
|
C25H32FNO2 |
详情 |
详情
|
(XI) |
24613 |
(3R,5S)-5-[(1R)-1-bromo-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone
|
|
C15H18BrFO2 |
详情 |
详情
|
(XII) |
24614 |
(3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone
|
|
C15H18FN3O2 |
详情 |
详情
|
(XIII) |
24615 |
tert-butyl (1S)-1-[(2S,4R)-4-(4-fluorobenzyl)-5-oxotetrahydro-2-furanyl]-2-methylpropylcarbamate
|
|
C20H28FNO4 |
详情 |
详情
|
(XIV) |
24616 |
(2R,4S,5S)-5-[(tert-butoxycarbonyl)amino]-2-(4-fluorobenzyl)-4-hydroxy-6-methylheptanoic acid
|
|
C20H30FNO5 |
详情 |
详情
|
(XV) |
24617 |
(2R,5S)-5-[(tert-butoxycarbonyl)amino]-2-(4-fluorobenzyl)-6-methyl-4-oxoheptanoic acid
|
|
C20H28FNO5 |
详情 |
详情
|
合成路线45
该中间体在本合成路线中的序号:
(I) Diethyl malonate (I) was alkylated with 2-bromoethyl ethyl ether (II) in the presence of NaOEt to provide diethyl 2-(ethoxyethyl)malonate (III). Treatment of 2-chloronitrobenzene (IV) with 2,2,2-trifluoroethanol (V) afforded the trifluoroethyl ether (VI). Subsequent reduction of the nitro group of (VI) by means of iron in acetic acid gave aniline (VII), which was condensed with malonate (III) in refluxing diphenyl ether, yielding furoquinoline (VIII). Further reaction of (VIII) with o-toluidine (IX) in boiling diethylene glycol produced the tetrahydropyrroloquinoline (X). Aromatization of the pyrrole ring of (X) to give (XI) was achieved by dehydrogenation in diphenyl ether in the presence of Pd/C. Chloroquinoline (XII) was then obtained by chlorination of (XI) with POCl3. Finally, displacement of the chlorine atom of (XII) by means of ethanolamine at 180 C furnished the title compound.
【1】
Kim, H.-J.; Kim, S.-S.; Yoo, Y.-K.; Kang, S.-K.; Cheon, H.-G.; Choi, J.-K.; Yum, E.-K. (Korea Research Institute of Chemical Technology); Pyrrolo[3,2-c]quinoline derivs. containing haloalkoxy group and pharmaceutically acceptable salts thereof. CA 2268166; EP 0966466; JP 2000504352; US 6011044; WO 9909029 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
34659 |
2-bromoethyl ethyl ether; 1-bromo-2-ethoxyethane
|
592-55-2 |
C4H9BrO |
详情 | 详情
|
(III) |
34660 |
diethyl 2-(2-ethoxyethyl)malonate
|
|
C11H20O5 |
详情 |
详情
|
(IV) |
15248 |
1-chloro-2-nitrobenzene
|
88-73-3 |
C6H4ClNO2 |
详情 | 详情
|
(V) |
19483 |
2,2,2-trifluoro-1-ethanol
|
75-89-8 |
C2H3F3O |
详情 | 详情
|
(VI) |
29562 |
2-nitrophenyl 2,2,2-trifluoroethyl ether; 1-nitro-2-(2,2,2-trifluoroethoxy)benzene
|
|
C8H6F3NO3 |
详情 |
详情
|
(VII) |
29563 |
2-(2,2,2-trifluoroethoxy)aniline; 2-(2,2,2-trifluoroethoxy)phenylamine
|
|
C8H8F3NO |
详情 |
详情
|
(VIII) |
34661 |
6-(2,2,2-trifluoroethoxy)-3,5-dihydrofuro[3,2-c]quinolin-4(2H)-one
|
|
C13H10F3NO3 |
详情 |
详情
|
(IX) |
15511 |
o-toluidine; 2-methylphenylamine;2-Methylaniline;2-Aminotoluene;1-Amino-2-methylbenzene;1-Methyl-2-aminobenzene; ortho-Toluidine |
95-53-4 |
C7H9N |
详情 | 详情
|
(X) |
34662 |
1-(2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C20H17F3N2O2 |
详情 |
详情
|
(XI) |
34663 |
1-(2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1,5-dihydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C20H15F3N2O2 |
详情 |
详情
|
(XII) |
34664 |
4-chloro-1-(2-methylphenyl)-6-(2,2,2-trifluoroethoxy)-1H-pyrrolo[3,2-c]quinoline; 4-chloro-1-(2-methylphenyl)-1H-pyrrolo[3,2-c]quinolin-6-yl 2,2,2-trifluoroethyl ether
|
|
C20H14ClF3N2O |
详情 |
详情
|
合成路线46
该中间体在本合成路线中的序号:
2-Chloro-2',4'-difluoroacetophenone (I) was converted to acetate ester (II) by displacement of the chlorine with sodium acetate in the presence of NaI. Subsequent Wittig reaction of (II) with methylenetriphenylphosphorane produced the allyl ester (III), which was hydrolyzed to alcohol (IV) with KOH in aqueous dioxan. Asymmeytric Sharpless epoxidation of (IV) with tert-butyl hydroperoxide in the presence of L-(+)-diethyl tartrate and titanium tetraisopropoxide furnished the (S)-epoxide (V). Ring opening of (V) with the sodium salt of 1,2,4-triazole (VI) gave the triazolyl diol (VII). After conversion of the primary hydroxyl group to tosylate (VIII), ring closure in the presence of NaH generated epoxide (IX). Condensation of (IX) with diethyl malonate afforded a mixture of diastereomeric butyrolactones (Xa, Xb), which was converted to triol (XI) by reduction with lithium borohydride. Treatment of (XI) with p-toluenesulfonyl chloride produced ditosylate (XII). Ring closure of (XII) employing NaH in boiling toluene gave rise to a diastereomeric mixture of tetrahydrofurans, from which the required cis isomer (XIII) was isolated by column chromatography.
【1】
Saksena, A.K.; Girijavallabhan, V.M.; Lovey, R.G.; Pike, R.E.; Wang, H.; Liu, Y.-T.; Ganguly, A.K.; Bennett, F. (Schering Corp.); Tetrahydrofuran antifungals. EP 0773941; WO 9638443 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(Xa) |
34838 |
ethyl (3S,5R)-5-(2,4-difluorophenyl)-2-oxo-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furancarboxylate
|
|
C16H15F2N3O4 |
详情 |
详情
|
(Xb) |
34839 |
ethyl (3R,5R)-5-(2,4-difluorophenyl)-2-oxo-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furancarboxylate
|
|
C16H15F2N3O4 |
详情 |
详情
|
(I) |
16321 |
2-Chloro-2',4'-difluoroacetophenone; 2-Chloro-1-(2,4-difluorophenyl)-1-ethanone
|
51336-94-8 |
C8H5ClF2O |
详情 | 详情
|
(II) |
16322 |
2-(2,4-Difluorophenyl)-2-oxoethyl acetate
|
|
C10H8F2O3 |
详情 |
详情
|
(III) |
16323 |
2-(2,4-difluorophenyl)-2-propenyl acetate
|
|
C11H10F2O2 |
详情 |
详情
|
(IV) |
15491 |
2-(2,4-difluorophenyl)-2-propen-1-ol
|
|
C9H8F2O |
详情 |
详情
|
(V) |
17058 |
[(2S)-2-(2,4-difluorophenyl)oxiranyl]methanol
|
|
C9H8F2O2 |
详情 |
详情
|
(VI) |
13135 |
1H-1,2,4-Triazole; 1,2,4-Triazole
|
288-88-0 |
C2H3N3 |
详情 | 详情
|
(VII) |
16327 |
(2R)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol
|
|
C11H11F2N3O2 |
详情 |
详情
|
(VIII) |
16328 |
(2R)-2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl methanesulfonate
|
|
C12H13F2N3O4S |
详情 |
详情
|
(IX) |
15477 |
1-[[(2R)-2-(2,4-difluorophenyl)oxiranyl]methyl]-1H-1,2,4-triazole
|
|
C11H9F2N3O |
详情 |
详情
|
(XI) |
16332 |
(4R)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)-5-(1H-1,2,4-triazol-1-yl)-1,4-pentanediol
|
|
C14H17F2N3O3 |
详情 |
详情
|
(XII) |
17066 |
(4R)-4-(2,4-difluorophenyl)-4-hydroxy-2-([[(4-methylphenyl)sulfonyl]oxy]methyl)-5-(1H-1,2,4-triazol-1-yl)pentyl 4-methylbenzenesulfonate
|
|
C28H29F2N3O7S2 |
详情 |
详情
|
(XIII) |
16311 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-methylbenzenesulfonate
|
|
C21H21F2N3O4S |
详情 |
详情
|
合成路线47
该中间体在本合成路线中的序号:
(I) Diethyl diazomalonate (III) was prepared by reaction of diethyl malonate (I) with p-tosyl azide (II) in the presence of Et3N. Subsequent coupling of (II) with 4-hydroxytetrahydropyran (IV) using dirhodium tetraacetate as the catalyst afforded ether (V). Alkylation of (V) with 3-(tert-butoxycarbonylamino)propyl bromide (VI) yielded adduct (VII). Finally, hydrolysis of ester groups of (VII) employing LiOH furnished the title dicarboxylic acid lithium salt.
【1】
Fiorentino, S.; Allegretti, M.; Mantovanini, M.; Clavenna, G.; Caselli, G.; Gandolfi, C.A. (Dompé Farmaceutici SpA); Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism. EP 0792878; US 5908863 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
37748 |
4-methylbenzenesulfonyl azide
|
941-55-9 |
C7H7N3O2S |
详情 | 详情
|
(III) |
37749 |
diethyl 2-diazomalonate
|
|
C7H10N2O4 |
详情 |
详情
|
(IV) |
37750 |
tetrahydro-2H-pyran-4-ol; 4-Hydroxytetrahydropyran |
2081-44-9 |
C5H10O2 |
详情 | 详情
|
(V) |
37751 |
diethyl 2-(tetrahydro-2H-pyran-4-yloxy)malonate
|
|
C12H20O6 |
详情 |
详情
|
(VI) |
37752 |
tert-butyl 3-bromopropylcarbamate
|
|
C8H16BrNO2 |
详情 |
详情
|
(VII) |
37753 |
diethyl 2-[3-[(tert-butoxycarbonyl)amino]propyl]-2-(tetrahydro-2H-pyran-4-yloxy)malonate
|
|
C20H35NO8 |
详情 |
详情
|
合成路线48
该中间体在本合成路线中的序号:
(A) Treatment of a commercial mixture of 4-chloro-tetrafluropyridine (I) and 3-chlorotetrafluoropyridine (II) with sodium tert-butoxide, followed by chromatographic separation, afforded 4-tert-butoxy-3-chloro-2,5,6-trifluoropyridine (III). Subsequent hydrogenolysis of the chlorine atom of (III) provided (IV), which was methylated with iodomethane in the presence of LDA yielding methylpyridine (V). Selective removal of the 6-fluorine of (V) to give (VI) was achieved by treatment with hydrazine hydrate in boiling n-propanol, followed by air oxidation of the intermediate pyridyl hydrazine. Alkylation of cyclopropaneacetonitrile (VII) with (VI) furnished the pyridinyl cyclopropaneacetonitrile (VIII). After acid cleavage of the tert-butyl group of (VIII), treatment with phosphoryl chloride in DMF gave rise to 4-chloropyridine derivative (IX). Then, alcoholysis of the cyano group of (IX) produced ethyl ester (X). Ester reduction by means of LiAlH4 and subsequent Swern oxidation of the resulting alcohol (XI) provided aldehyde (XII). The required quinolizinone system (XIII) was prepared by Knoevenagel condensation of pyridine aldehyde (XII) with diethyl malonate (1). The chiral piperidine (XV) was obtained by chiral HPLC resolution of racemic cis-N-carbobenzoxy-3-(tert-butoxycarbonylamino)-4-methylpiperidine (XIV), followed by hydrogenolytic cleavage of the carbobenzoxy group. Aromatic substitution of chloroquinolizinone (XIII) with piperidine (XV) yielded adduct (XVI). Hydrolysis of the ethyl ester of (XVI) with LiOH and further acid deprotection of the Boc group furnished the title compound.
【1】
Wang, S.; Ma, Z.; Flamm, R.K.; Cooper, C.S.; Li, Q.; Nilius, J.D.; Chu, D.T.W.; Sun OR, Y.; Meulbroek, J.A.; Shen, L.L.; Fung, A.K.L.; Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: Consequences of structural modification at the C-8 position. J Med Chem 1999, 42, 20, 4202. |
【2】
Chu, D.T.; Li, Q.; Cooper, C.S.; Fung, A.K.L.; Lee, C.M.; Plattner, J.J.; Ma, Z.; Wang, W.-B. (Abbott Laboratories Inc.); Quinolizinone type cpds.. EP 0871628; JP 1999510478; WO 9639407 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(I) |
40621 |
4-chloro-2,3,5,6-tetrafluoropyridine
|
|
C5ClF4N |
详情 |
详情
|
(II) |
16819 |
3-chloro-2,4,5,6-tetrafluoropyridine; Pyridine, 3-chloro-2,4,5,6-tetrafluoro-
|
1735-84-8 |
C5ClF4N |
详情 | 详情
|
(III) |
16820 |
4-(tert-butoxy)-3-chloro-2,5,6-trifluoropyridine; tert-butyl 3-chloro-2,5,6-trifluoro-4-pyridinyl ether
|
|
C9H9ClF3NO |
详情 |
详情
|
(IV) |
16821 |
4-(tert-butoxy)-2,3,6-trifluoropyridine; tert-butyl 2,3,6-trifluoro-4-pyridinyl ether
|
|
C9H10F3NO |
详情 |
详情
|
(V) |
16822 |
tert-butyl 2,3,6-trifluoro-5-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,3,6-trifluoro-5-methylpyridine
|
|
C10H12F3NO |
详情 |
详情
|
(VI) |
16823 |
tert-butyl 2,5-difluoro-3-methyl-4-pyridinyl ether; 4-(tert-butoxy)-2,5-difluoro-3-methylpyridine
|
|
C10H13F2NO |
详情 |
详情
|
(VII) |
16824 |
2-cyclopropylacetonitrile; Cyclopropylacetonitrile
|
6542-60-5 |
C5H7N |
详情 | 详情
|
(VIII) |
16825 |
2-[4-(tert-butoxy)-5-fluoro-3-methyl-2-pyridinyl]-2-cyclopropylacetonitrile
|
|
C15H19FN2O |
详情 |
详情
|
(IX) |
16826 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetonitrile
|
|
C11H10ClFN2 |
详情 |
详情
|
(X) |
16827 |
ethyl 2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetate
|
|
C13H15ClFNO2 |
详情 |
详情
|
(XI) |
31627 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropyl-1-ethanol
|
|
C11H13ClFNO |
详情 |
详情
|
(XII) |
16828 |
2-(4-chloro-5-fluoro-3-methyl-2-pyridinyl)-2-cyclopropylacetaldehyde
|
|
C11H11ClFNO |
详情 |
详情
|
(XIII) |
16831 |
ethyl 8-chloro-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C16H15ClFNO3 |
详情 |
详情
|
(XIV) |
40623 |
benzyl (3S,4S)-3-[(tert-butoxycarbonyl)amino]-4-methyl-1-piperidinecarboxylate
|
|
C19H28N2O4 |
详情 |
详情
|
(XV) |
40622 |
tert-butyl (3S,4S)-4-methylpiperidinylcarbamate
|
|
C11H22N2O2 |
详情 |
详情
|
(XVI) |
40624 |
ethyl 8-[(3S,4S)-3-[(tert-butoxycarbonyl)amino]-4-methylpiperidinyl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
|
|
C27H36FN3O5 |
详情 |
详情
|
合成路线49
该中间体在本合成路线中的序号:
(XVIII) An alternative procedure for the preparation of the carbapenem system was based on the desulfurative ring contraction of a 1-aza-3-thiabicyclo[4.2.0]octane. The required diethyl (mercaptomethyl)malonate (XXI) was prepared by condensation of diethyl malonate (XVIII) with paraformaldehyde to give methylene malonate (XIX). Conjugate addition of thioacetic acid to (XIX) afforded thioester (XX) and subsequent acid hydrolysis yielded the desired mercaptomethyl derivative (XXI). Coupling of (XXI) with azetidinonepropionic acid (XXII) via activation with CDI generated thioester (XXIII). Oxalic acid chloride isobutyryloxymethyl ester (XXV) was obtained from isobutyryl chloride (XXIV) by condensation with paraformaldehyde, followed by reaction of the resulting chloromethylbutyrate with monobenzyl oxalate tetrabutylammonium salt, hydrogenolysis of the benzyl group and chlorination with oxalyl chloride. Coupling of this acid chloride (XXV) with azetidinone (XXIII) gave imide (XXVI), which was reduced to the hydroxy derivative (XXVII) with Zn and AcOH. After chlorination of (XXVII) with SOCl2 and pyridine, cleavage of the methylenemalonate group, followed by cyclization in the presence of Et3N gave rise to the bicyclic system (XXIX).
【1】
Horikawa, H.; Iwasaki, T.; Kondo, K. (Tanabe Seiyaku Co., Ltd.); Process for preparing beta-lactam deriv. and synthetic intermediate thereof. EP 0559533 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XIX) |
37725 |
diethyl 2-methylenemalonate
|
|
C8H12O4 |
详情 |
详情
|
(XX) |
37726 |
diethyl 2-[(acetylsulfanyl)methyl]malonate
|
|
C10H16O5S |
详情 |
详情
|
(XXI) |
37727 |
diethyl 2-(sulfanylmethyl)malonate
|
|
C8H14O4S |
详情 |
详情
|
(XXII) |
30029 |
(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propionic acid
|
|
C14H27NO4Si |
详情 |
详情
|
(XXIII) |
37728 |
diethyl 2-[([(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propanoyl]sulfanyl)methyl]malonate
|
|
C22H39NO7SSi |
详情 |
详情
|
(XXIV) |
14932 |
isobutyryl chloride; 2-methylpropanoyl chloride
|
79-30-1 |
C4H7ClO |
详情 | 详情
|
(XXV) |
37729 |
[(2-chloro-2-oxoacetyl)oxy]methyl 2-methylpropanoate
|
|
C7H9ClO5 |
详情 |
详情
|
(XXVI) |
37730 |
diethyl 2-[([(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-1-(2-[[(3-methylbutanoyl)oxy]methoxy]-2-oxoacetyl)-4-oxoazetidinyl]propanoyl]sulfanyl)methyl]malonate
|
|
C30H49NO12SSi |
详情 |
详情
|
(XXVII) |
37731 |
diethyl 2-[([(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-1-(1-hydroxy-2-[[(3-methylbutanoyl)oxy]methoxy]-2-oxoethyl)-4-oxoazetidinyl]propanoyl]sulfanyl)methyl]malonate
|
|
C30H51NO12SSi |
详情 |
详情
|
(XXVIII) |
37732 |
diethyl 2-[([(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-1-(1-chloro-2-[[(3-methylbutanoyl)oxy]methoxy]-2-oxoethyl)-4-oxoazetidinyl]propanoyl]sulfanyl)methyl]malonate
|
|
C30H50ClNO11SSi |
详情 |
详情
|
(XXIX) |
37733 |
(isobutyryloxy)methyl (5R,6S,7S)-7-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-5-methyl-4,8-dioxo-3-thia-1-azabicyclo[4.2.0]octane-2-carboxylate
|
|
C21H35NO7SSi |
详情 |
详情
|
合成路线50
该中间体在本合成路线中的序号:
(II) The cyclization of 4-guanidinobenzonitrile (I) with diethyl malonate (II) by means of NaOEt in ethanol gives 4-(4,6-dihydroxypyrimidin-2-ylamino)benzonitrile (III), which is treated with POCl3 to yield the corresponding dichloro derivative (IV). The bromination of (IV) with Br2 and NaHCO3 in methanol/water affords 4-(5-bromo-4,6-dichloropyrimidin-2-ylamino)benzonitrile (V), which is condensed with sodium 4-cyano-2,6-dimethylphenolate (VI) and N-methylpyrrolidone in dioxane to provide the chloro precursor (VII). Finally, this compound is treated with ammonia in isopropanol to yield the target dinitrile derivative.
【1】
Ludovici, D.W.; De Corte, B.L.; Kukla, M.J.; et al.; Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. Bioorg Med Chem Lett 2001, 11, 17, 2235.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
55735 |
N-(4-cyanophenyl)guanidine
|
|
C8H8N4 |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
55736 |
4-[(4,6-dihydroxy-2-pyrimidinyl)amino]benzonitrile
|
|
C11H8N4O2 |
详情 |
详情
|
(IV) |
55737 |
4-[(4,6-dichloro-2-pyrimidinyl)amino]benzonitrile
|
|
C11H6Cl2N4 |
详情 |
详情
|
(V) |
46617 |
4-[(5-bromo-4,6-dichloro-2-pyrimidinyl)amino]benzonitrile
|
|
C11H5BrCl2N4 |
详情 |
详情
|
(VI) |
55738 |
sodium 4-cyano-2,6-dimethylbenzenolate
|
|
C9H8NNaO |
详情 |
详情
|
(VII) |
55739 |
ethyl 1-(2-{[(1S)-1-phenylethyl]amino}acetyl)cyclopropanecarboxylate
|
|
C16H21NO3 |
详情 |
详情
|
合成路线51
该中间体在本合成路线中的序号:
(II) Condensation of 4-vinylpyridine (I) with diethyl malonate (II) affords the bis(pyridylethyl)malonate (III) which, upon acidic hydrolysis and decarboxylation leads to mono-acid (IV). Catalytic hydrogenation of the pyridine rings of (IV) in the presence of Pd/C furnishes the corresponding piperidinyl compound (V), which is further protected as the N-Boc derivative (VI) employing di-t-butyl dicarbonate. Acid (VI) is coupled to glycine methyl ester (VII) via activation with cyanuric fluoride to yield amide (VIII). Then, alkaline hydrolysis of the methyl ester group provides carboxylic acid (IX).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45857 |
4-vinylpyridine
|
|
C7H7N |
详情 |
详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
63020 |
diethyl 2,2-bis[2-(4-pyridinyl)ethyl]malonate
|
|
C21H26N2O4 |
详情 |
详情
|
(IV) |
63022 |
4-(4-pyridinyl)-2-[2-(4-pyridinyl)ethyl]butanoic acid
|
|
C16H18N2O2 |
详情 |
详情
|
(V) |
63023 |
4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl]butanoic acid
|
|
C16H30N2O2 |
详情 |
详情
|
(VI) |
63024 |
4-[1-(tert-butoxycarbonyl)-4-piperidinyl]-2-{2-[1-(tert-butoxycarbonyl)-4-piperidinyl]ethyl}butanoic acid
|
|
C26H46N2O6 |
详情 |
详情
|
(VII) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(VIII) |
63025 |
tert-butyl 4-(5-[1-(tert-butoxycarbonyl)-4-piperidinyl]-3-{[(2-methoxy-2-oxoethyl)amino]carbonyl}pentyl)-1-piperidinecarboxylate
|
|
C29H51N3O7 |
详情 |
详情
|
(IX) |
63026 |
2-[(4-[1-(tert-butoxycarbonyl)-4-piperidinyl]-2-{2-[1-(tert-butoxycarbonyl)-4-piperidinyl]ethyl}butanoyl)amino]acetic acid
|
|
C28H49N3O7 |
详情 |
详情
|
合成路线52
该中间体在本合成路线中的序号:
(II) The condensation of 3-pyridincarboxaldehyde (I) with diethyl malonate (II) by means of piperidine in refluxing benzene gives diethyl (3-pyridyl)methylenemalonate (III), which by reaction with dimethylamine (A) in ether is converted into diethyl alpha-dimethylamino-(3-pyridyl)methylmalonate (IV). The reduction of (IV) with LiAlH4 in THF affords 2-[alpha-dimethylamino-(3-pyridyl)methyl]-1,3-propanediol (V), which is finally cyclized with paraformaldehyde by means of boron trifluoride ethearate in acetonitrile. (1-3)
【1】
Booher, R.N. (Eli Lilly and Company); US 3905987 .
|
【2】
Blancafort, P.; Serradell, M.N.; Castaner, J.; Doxpicomine hydrochloride. Drugs Fut 1981, 6, 9, 548.
|
【3】
Booher, R.N.; et al.; Various 5-substituted and 2,5-disubstituted 1,3-dioxanes, a new class of analgesic agents. J Med Chem 1977, 20, 7, 885.
|
【4】
Booher, R.N. (Eli Lilly and Company); US 3962269 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
19443 |
N-methylmethanamine; N,N-dimethylamine
|
124-40-3 |
C2H7N |
详情 | 详情
|
(I) |
12849 |
Nicotinaldehyde; 3-Pyridinecarboxaldehyde
|
500-22-1 |
C6H5NO |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
60974 |
diethyl 2-(3-pyridinylmethylene)malonate
|
|
C13H15NO4 |
详情 |
详情
|
(IV) |
60975 |
diethyl 2-[(dimethylamino)(3-pyridinyl)methyl]malonate
|
|
C15H22N2O4 |
详情 |
详情
|
(V) |
60976 |
2-[(dimethylamino)(3-pyridinyl)methyl]-1,3-propanediol
|
|
C11H18N2O2 |
详情 |
详情
|
合成路线53
该中间体在本合成路线中的序号:
(I) Diethyl malonate (I) was alkylated with 2-bromoethyl ethyl ether (II) to provide diethyl (2-ethoxyethyl)malonate (III). Subsequent condensation of malonate (III) with 2-(trifluoromethoxy)aniline (IV) in boiling diphenyl ether generated the furoquinoline derivative (V). This was then condensed with 2-methyl-4-methoxyaniline (VI) in refluxing diethylene glycol to furnish adduct (VII). Chlorination of pyrroloquinolone (VII) with phosphoryl chloride gave rise to the chloro pyrroloquinoline (VIII). The chloro group of (VIII) was finally displaced with ethanolamine (IX) at 190 C, yielding the title compound.
【1】
Kim, H.-J.; Kim, S.-S.; Yoo, Y.-K.; Kang, S.-K.; Cheon, H.-G.; Choi, J.-K.; Yum, E.-K. (Korea Research Institute of Chemical Technology); Pyrrolo[3,2-c]quinoline derivs. containing haloalkoxy group and pharmaceutically acceptable salts thereof. CA 2268166; EP 0966466; JP 2000504352; US 6011044; WO 9909029 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(II) |
34659 |
2-bromoethyl ethyl ether; 1-bromo-2-ethoxyethane
|
592-55-2 |
C4H9BrO |
详情 | 详情
|
(III) |
34660 |
diethyl 2-(2-ethoxyethyl)malonate
|
|
C11H20O5 |
详情 |
详情
|
(IV) |
51625 |
2-trifluoromethoxyaniline; alpha,alpha,alpha-trifluoro-o-anisidine; o-trifluoromethoxyaniline
|
1535-75-7 |
C7H6F3NO |
详情 | 详情
|
(V) |
51626 |
6-(trifluoromethoxy)-3,5-dihydrofuro[3,2-c]quinolin-4(2H)-one
|
|
C12H8F3NO3 |
详情 |
详情
|
(VI) |
40006 |
4-methoxy-2-methylphenylamine; 4-methoxy-2-methylaniline
|
102-50-1 |
C8H11NO |
详情 | 详情
|
(VII) |
51627 |
1-(4-methoxy-2-methylphenyl)-6-(trifluoromethoxy)-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-c]quinolin-4-one
|
|
C20H17F3N2O3 |
详情 |
详情
|
(VIII) |
51628 |
4-chloro-1-(4-methoxy-2-methylphenyl)-6-(trifluoromethoxy)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline; 4-chloro-1-(4-methoxy-2-methylphenyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinolin-6-yl trifluoromethyl ether
|
|
C20H16ClF3N2O2 |
详情 |
详情
|
(IX) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
合成路线54
该中间体在本合成路线中的序号:
(VI) The condensation of 5-chloro-2-nitroanisole (V) with diethyl malonate (VI) by means of NaH in hot DMF gives 2-(3-methoxy-4-nitrophenyl)malonic acid diethyl ester (VII), which is reduced with H2 over Pd/C in ethyl acetate, yielding the corresponding amino derivative (VIII). The condensation of (VIII) with 2-methylphenyl isocyanate (IX) by means of TEA in dichloromethane affords the expected urea (X), which is submitted to a decarboxylative hydrolysis with NaOH in refluxing tert-butanol to provide the phenylacetic acid (XI). The condensation of acetic acid (XI) with the amino group of the isoxazole intermediate (IV) by means of HOBt, DIEA and EDC in DMF gives the amide (XII), which is treated with NaOH in tert-butanol to afford the target propionic acid.
【1】
Duplantier, A.J.; et al.; Isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives as potent alpha4beta1 integrin antagonists. Bioorg Med Chem Lett 2001, 11, 19, 2593.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
51635 |
methyl 3-[3-[(1S)-1-amino-3-methylbutyl]-5-isoxazolyl]propanoate
|
|
C12H20N2O3 |
详情 |
详情
|
(V) |
51636 |
4-Chloro-2-methoxy-1-nitrobenzene; 4-Chloro-2-methoxynitrobenzene; 5-Chloro-2-nitroanisole
|
6627-53-8 |
C7H6ClNO3 |
详情 | 详情
|
(VI) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(VII) |
51637 |
diethyl 2-(3-methoxy-4-nitrophenyl)malonate
|
|
C14H17NO7 |
详情 |
详情
|
(VIII) |
51638 |
diethyl 2-(4-amino-3-methoxyphenyl)malonate
|
|
C14H19NO5 |
详情 |
详情
|
(IX) |
27106 |
1-isocyanato-2-methylbenzene
|
614-68-6 |
C8H7NO |
详情 | 详情
|
(X) |
51639 |
diethyl 2-[3-methoxy-4-[(2-toluidinocarbonyl)amino]phenyl]malonate
|
|
C22H26N2O6 |
详情 |
详情
|
(XI) |
39718 |
2-[3-methoxy-4-[(2-toluidinocarbonyl)amino]phenyl]acetic acid
|
|
C17H18N2O4 |
详情 |
详情
|
(XII) |
51640 |
methyl 3-(3-[(1S)-1-[(2-[3-methoxy-4-[(2-toluidinocarbonyl)amino]phenyl]acetyl)amino]-3-methylbutyl]-5-isoxazolyl)propanoate
|
|
C29H36N4O6 |
详情 |
详情
|
合成路线55
该中间体在本合成路线中的序号:
(II) Cyclization of morpholine-4-carboximidamide hydrobromide (I) with diethyl malonate (II) by means of naoEt in refluxing EtoH gives 2-(morpholin-4-yl)pyrimidine-4,6-diol (III), which by chlorination with PoCl3 at 120 °C affords 4,6-dichloro-2-(morpholin-4-yl)pyrimidine (IV). nucleophilic substitution of the dichloropyrimidine (IV) with morpholine (V) in the presence of Et3n in refluxing N-methyl-2-pyrrolidone provides 2,4-di(morpholin-4-yl)-6-chloropyrimidine (VI) . Alternatively, dimorpholinopyrimidine (VI) is prepared by reaction of 2,4,6-trichloropyrimidine (VII) with morpholine (V) in THF, followed by chromatographic separation . Finally, chloropyrimidine derivative (VI) is submitted to a Suzuki cross-coupling reaction with boronate ester (VIII) in the presence of Pd(dppf)2Cl2·CH2Cl2 or Pd(dppf)2Cl2 and na2Co3 in 1,2-dimethoxyethane at 90-95 °C .
Alternatively, iodination of chloride (VI) with HI and naI yields the corresponding iodide (IX) , which is also coupled with boronate (VIII) in the presence of Pd(dppf)Cl2·CH2Cl2 and K2Co3 in 1,4-dioxane/H2o at 100 °C .
Boronate ester (VIII) is obtained by bromination of 4-(trifluoromethyl) pyridin-2-amine (X) with nBS in CHCl3 or CH2Cl2 to afford 5-bromo-4-(trifluoromethyl)pyrimidin-2-amine (XI), which is finally condensed with bis(pinacolato)diboron (XII) in the presence of Pd(dppf)2Cl2·CH2Cl2 and KoAc in refluxing dioxane or DMSO .
【1】
Pick, T., Barsanti, P., Iwanowicz, E. et al. (novartis AG). Pyrimidine derivatives used as PI-3 kinase inhibitors. EP 1984350, EP 2261223, JP 200952764, US 2010249126, US 8217035, US 2012225859, Wo 2007084786. |
【2】
Burger, M.T., Pecchi, S., Wagman, A. et al. Discovery of BKM120, a pan class I PI3 kinase inhibitor in phase I/II clinical trials. 240th ACS natl Meet (Aug 22-26, Boston) 2010, Abst MEDI 489. |
【3】
Vu, A.T., Morris, J. Malhotra, S.V. Efficient and improved synthesis of a PI3K inhibitor anticancer agent. 241st ACS natl Meet (March 27-31, Anaheim) 2011, Abst oRGn 115. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
67957 |
morpholine-4-carboximidamide hydrobromide |
|
C5H11N3O.HBr |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
67958 |
2-morpholinopyrimidine-4,6-diol |
|
C8H11N3O3 |
详情 | 详情
|
(IV) |
67959 |
4,6-dichloro-2-(morpholin-4-yl)pyrimidine |
10397-13-4 |
C8H9Cl2N3O |
详情 | 详情
|
(V) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(VI) |
67960 |
4,4'-(6-chloropyrimidine-2,4-diyl)dimorpholine |
|
C12H17ClN4O2 |
详情 | 详情
|
(VII) |
43734 |
2,4,6-trichloropyrimidine
|
3764-01-0 |
C4HCl3N2 |
详情 | 详情
|
(VIII) |
67961 |
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
|
C12H16BF3N2O2 |
详情 | 详情
|
(IX) |
67962 |
4,4'-(6-iodopyrimidine-2,4-diyl)dimorpholine |
|
C12H17IN4O2 |
详情 | 详情
|
(X) |
67963 |
4-(trifluoromethyl)pyridin-2-amine |
106447-97-6 |
C6H5F3N2 |
详情 | 详情
|
(XI) |
67964 |
5-bromo-4-(trifluoromethyl)pyridin-2-amine |
|
C6H4BrF3N2 |
详情 | 详情
|
(XII) |
53342 |
4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane; Bis(pinacolato)diboron; Diboron pinacol ester
|
73183-34-3 |
C12H24B2O4 |
详情 | 详情
|